TempV

34012335 2021. Vaccine against SARS-CoV-2: Challenges and considerations.
33933606 2021. COVID-19 Vaccination Prioritization on the Basis of Cardiovascular Risk Factors and Number Needed to Vaccinate to Prevent Death.
33936347 2021. Immunoinformatics Identification of B- and T-Cell Epitopes in the RNA-Dependent RNA Polymerase of SARS-CoV-2.
34055430 2021. Exacerbating Guillain-Barre Syndrome Eight Days after Vector-Based COVID-19 Vaccination.
34076125 2021. Vacinas: Da Saude Publica ao Big Business.
33938790 2021. Provisional recommendations for SARS-CoV-2 vaccination in patients with cryoglobulinaemic vasculitis.
34053731 2021. Unilateral axillary adenopathy following COVID-19 vaccination: a multimodality pictorial illustration and review of current guidelines.
33824804 2021. Untimely Myocardial Infarction or COVID-19 Vaccine Side Effect.
33968515 2021. Rapid Development of Clinically Symptomatic Radiation Recall Pneumonitis Immediately Following COVID-19 Vaccination.
34084669 2021. Acute Pancreatitis: A Possible Side Effect of COVID-19 Vaccine.
33996313 2021. BCG Scar Local Skin Inflammation as a Novel Reaction Following mRNA COVID-19 Vaccines in Two International Healthcare Workers.
33845349 2021. Supply and delivery of vaccines for global health.
34000712 2021. Focal onset non-motor seizure following COVID-19 vaccination: A mere coincidence?
33991805 2021. Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India.
33888439 2021. Myocardial infarction after COVID-19 vaccination-casual or causal?
33962903 2021. Imaging of Oxford/AstraZeneca(R) COVID-19 vaccine-induced immune thrombotic thrombocytopenia.
34064509 2021. Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination.
34073536 2021. COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility Diagnosis.
34070341 2021. Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?
34075362 2021. The Uro-oncology Patient and Vaccination Against SARS-CoV-2.
34047271 2021. Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021.
34018481 2021. The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant.
33959579 2021. Barriers Influencing Vaccine Development Timelines, Identification, Causal Analysis, and Prioritization of Key Barriers by KOLs in General and Covid-19 Vaccine R&D.
33903149 2021. Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD.
34011137 2021. Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia.
34026475 2021. Surmounting inherent challenges in healthcare service delivery for effective procurement and distribution of COVID-19 vaccines; A developing country context.
34103937 2021. Vaccination and the Prevention of Communicable Diseases in Healthcare Settings: Lessons from the Covid-19 Pandemic.
33855127 2021. A Higher Number of Covid19 Cases and Fatalities in Israel Phased With the Start of the Mass Vaccination.
33916122 2021. Safety and Efficacy of Vaccines during COVID-19 Pandemic in Patients Treated with Biological Drugs in a Dermatological Setting.
33968610 2021. Guillain-Barre syndrome following the first dose of SARS-CoV-2 vaccine: A temporal occurrence, not a causal association.
33908359 2021. Problematic Covid-19 vaccine trials in times of vaccine nationalism.
33908358 2021. Placebo-controlled trials of Covid-19 vaccines - Are they still ethical?
33908357 2021. Testing vaccines in the time of Covid: The changing landscape.
33908356 2021. "No" to placebo-controlled trials of Covid-19 vaccines.
33908354 2021. The continued use of placebo arms in COVID-19 vaccine trials does not adequately protect the well-being of participants.
33908353 2021. Placebo control in Covid-19 trials: A missed opportunity for international guidance.
33908352 2021. Trials for second generation Covid-19 vaccines: Revisiting the debate over placebo use in developing country clinical trials.
33908351 2021. Placebo in new Covid-19 vaccine trials: data quality prioritised over participants' rights.
33908350 2021. Ethical limits to placebo use and access to Covid-19 vaccines as a human right.
34099338 2021. Breakthrough COVID-19 case after full-dose administration of CoronaVac vaccine.
33361645 2021. Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates.
33361644 2021. The quest continues for perfect COVID-19 vaccine.
33938416 2021. "Original antigenic sin": A potential threat beyond the development of booster vaccination against novel SARS-CoV-2 variants.
33963523 2021. Coincidental SARS-CoV-2 infection and mRNA vaccination: a case report addressing the most important clinical questions.
34066995 2021. Facial and Oral Manifestations Following COVID-19 Vaccination: A Survey-Based Study and a First Perspective.
34047035 2021. COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement.
33826780 2021. Harnessing the nursing contribution to COVID-19 mass vaccination programmes: Addressing hesitancy and promoting confidence.
34048595 2021. Early success of COVID-19 vaccines in nursing homes: Will it stick?
33955567 2021. The BNT162b2 vaccine is associated with lower new COVID-19 cases in nursing home residents and staff.
33861873 2021. Short-term impact of nursing home SARS-CoV-2 vaccinations on new infections, hospitalizations, and deaths.
33861871 2021. Proportion of SARS-CoV-2 positive tests and vaccination in Veterans Affairs Community Living Centers.
34048614 2021. Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle?
34021625 2021. Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from Northeast Italy.
33982814 2021. Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine.
33982318 2021. Recurrent injection-site reactions after incorrect subcutaneous administration of a COVID-19 vaccine.
34058038 2021. Ipsilateral herpes zoster after the first dose of BNT162b2 mRNA COVID-19 vaccine.
34077572 2021. Immune thrombocytopenic purpura associated with COVID-19 Pfizer-BioNTech BNT16B2b2 mRNA vaccine.
33914966 2021. BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2.
33914958 2021. Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report.
33899974 2021. Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance.
33834563 2021. Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 Vaccine: an Italian single-centre case series.
33905793 2021. Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study.
33989631 2021. Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021.
34008027 2021. Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials.
34007981 2021. Behind the Scenes Heroes: the COVID-19 Vaccine Data and Safety Monitoring Board.
34007998 2021. BNT162b2 mRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection: A Preliminary Report.
34003413 2021. Coronavirus Disease-19 Vaccines Best Reflect Effective Pharmaceuticals.
34000472 2021. Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients.
34032902 2021. Bell's palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report.
34023956 2021. Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis.
33864125 2021. Comment on the paper Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab: the likely explanation for this phenomenon based on our observations.
33844056 2021. Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus.
33762164 2021. A Shot at Inclusion: Reconsidering Categorical Exclusion of Hospice Patients from COVID Vaccine Allocation.
33941938 2021. Medical and ethical issues related to COVID-19 vaccine.
34059124 2021. Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech).
33321139 2021. Addressing the Cold Reality of mRNA Vaccine Stability.
34053350 2021. 2019 Novel Coronavirus Vaccination among Post-graduate Residents and Fellows.
33945346 2021. Assessing the long-term safety and efficacy of COVID-19 vaccines.
34018298 2021. Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology.
33931935 2021. Vaccine-induced immune thrombotic thrombocytopenia: Consider IVIG batch in the treatment.
33909350 2021. An observational study to identify the prevalence of thrombocytopenia and anti-PF4/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination.
33904251 2021. Post-adenoviral-based COVID-19 vaccines thrombosis: A proposed mechanism.
33877737 2021. Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine.
33877735 2021. Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT).
33973336 2021. Evaluation of laboratory assays for anti-platelet factor 4 antibodies after ChAdOx1 nCOV-19 vaccination.
34050372 2021. Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses.
34002240 2021. Neutralization of B.1.1.28 P2 variant with sera of natural SARS-CoV-2 infection and recipients of inactivated COVID-19 vaccine Covaxin.
34047765 2021. Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer.
34090624 2021. Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.
33890680 2021. Parsonage Turner syndrome after COVID-19 vaccination.
33851437 2021. Post COVID-19 vaccine small fiber neuropathy.
34036651 2021. SARS-CoV-2 mRNA vaccine-associated fixed drug eruption.
34085933 2021. Administration of the Comirnaty(R) Vaccine in a Fractional Regimen in Two Patients with Immediate Acute Urticaria after the First Dose.
34035134 2021. Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.
34035133 2021. Ischaemic stroke can follow COVID-19 vaccination but is much more common with COVID-19 infection itself.
33741644 2021. FDG Avid Axillary Lymph Nodes After COVID-19 Vaccination.
33893188 2021. Covid-19 mRNA Vaccination: Age and Immune Status and its Association with Axillary Lymph Node PET/CT Uptake.
33820864 2021. Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on (18)F-FDG PET/CT.
33658251 2021. Intramuscular Injections for COVID-19 Vaccinations.
34074678 2021. The COVID-19 Vaccine Landscape: What a Rheumatologist Needs to Know.
34076338 2021. The SSC platelet immunology register of VITT and VIITP: Toward standardization of laboratory and clinical parameters.
33904859 2021. Israel's Real-life Evidence That Vaccine Can Prevent Severe COVID-19.
33856406 2021. Spike Antibody Levels of Nursing Home Residents With or Without Prior COVID-19 3 Weeks After a Single BNT162b2 Vaccine Dose.
33835153 2021. Helping the Public Understand Adverse Events Associated With COVID-19 Vaccinations: Lessons Learned From Functional Neurological Disorder.
33983372 2021. COVID-19 Vaccines in Patients With Cancer-A Welcome Addition, but There Is Need for Optimization.
33974494 2021. Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination.
33731936 2021. Innovators target vaccines for variants and shortages in global South.
33972767 2021. A global database of COVID-19 vaccinations.
34021288 2021. 'It's a minefield': COVID vaccine safety poses unique communication challenge.
34012131 2021. Mix-and-match COVID vaccines trigger potent immune response.
33963317 2021. Pfizer COVID vaccine protects against worrying coronavirus variants.
33948031 2021. China's COVID vaccines are going global - but questions remain.

34051441 2021. SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors.
33829986 2021. Postvaccination COVID-19 among Healthcare Workers, Israel.
34034858 2021. Multisystem Inflammatory Syndrome after SARS-CoV-2 Infection and COVID-19 Vaccination.
34057040 2021. Intensified antibody response elicited by boost suggests immune memory in individuals administered two doses of SARS-CoV-2 inactivated vaccine.
34025118 2021. SARS-CoV-2 y los mitos sobre la vacunacion.
33858709 2021. Taquicardia como efecto adverso no descrito en la vacuna Comirnaty(c) (vacuna COVID-19 mRNA BNT162b2 de Pfizer-BioNTech): descripcion de 3 casos con antecedentes de SARS-CoV-2.
33968462 2021. COVID-19 Vaccine Allocation: Modeling Health Outcomes and Equity Implications of Alternative Strategies.
33898075 2021. Coronavirus Variants-Will New mRNA Vaccines Meet the Challenge?
34001753 2021. Theoretical Framework for Retrospective Studies of the Effectiveness of SARS-CoV-2 Vaccines.
34058493 2021. Estimated effect of COVID-19 vaccine in people with epilepsy.
33948639 2021. COVID-19 vaccine induced prothrombotic immune thrombocytopenia.
33928898 2021. Effectiveness of the Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers, Treviso province, Veneto region, Italy, 27 December 2020 to 24 March 2021.
33598436 2020. COVID-19, the Future Vaccine and What It Means for Cancer Patients on Immunotherapy.
33842684 2021. Temporal Relation Between Second Dose BNT162b2 mRNA Covid-19 Vaccine and Cardiac involvement in a Patient with Previous SARS-COV-2 Infection.
33368867 2021. Change in ectopic pregnancy presentations during the covid-19 pandemic.
33992761 2021. Post-vaccination cases of COVID-19 among healthcare workers at Siloam Teaching Hospital, Indonesia.
34022331 2021. Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals.
34022329 2021. Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection.
33992763 2021. The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout.
34044114 2021. Acute abducens nerve palsy following COVID-19 vaccination.
33866033 2021. COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach.
33864927 2021. "COVID Arm": Very delayed large injection site reactions to mRNA COVID-19 vaccines.
33831618 2021. COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM).
33892171 2021. The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis.
33838847 2021. PEG skin testing for COVID-19 vaccine allergy.
33838846 2021. Reply to "PEG skin testing for COVID-19 allergy".
33838206 2021. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.
33878412 2021. Response to comment on "An evidence-based guide to SARS-Cov-2 vaccination of patients on immunotherapies in dermatology."
33744352 2021. Comment on "An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology".
34057580 2021. PPAR agonists as effective adjuvants for COVID-19 vaccines, by modifying immunogenetics: a review of literature.
34006471 2021. COVID-19 mRNA vaccines.
33994322 2021. The challenge of emerging SARS-CoV-2 mutants to vaccine development.
34034958 2021. BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response.
34059088 2021. Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors.
34001183 2021. Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution.
34088334 2021. Hemophagocytic lymphohistiocytosis after COVID-19 vaccination.
33964372 2021. Comment on "Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?"
34052253 2021. High acceptance rate of COVID-19 vaccination in liver transplant recipients.
34048861 2021. Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipients.
34026245 2021. Induction of immune response after SARS-CoV-2 mRNA BNT162b2 vaccination in healthcare workers.
34026244 2021. Impact of COVID-19 and intensive care unit capacity on vaccination support: Evidence from a two-leg representative survey in the United Kingdom.
33872188 2021. Returning to a Normal Life via COVID-19 Vaccines in the United States: A Large-scale Agent-Based Simulation Study.
33907723 2021. Postvaccine Anti-SARS-CoV-2 Spike Protein Antibody Development in Kidney Transplant Recipients.
33972817 2021. TClustVID: A novel machine learning classification model to investigate topics and sentiment in COVID-19 tweets.
34038996 2021. Can reactogenicity predict immunogenicity after COVID-19 vaccination?
33285121 2021. Coronavirus vaccine? Join the queue.
34048723 2021. SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?
33961810 2021. Time for the ethical management of COVID-19 vaccines.
33910219 2021. Antibody Response to Coronavirus Disease 2019 (COVID-19) Messenger RNA Vaccination in Pregnant Women and Transplacental Passage Into Cord Blood.
33991381 2021. Coronavirus disease 2019 (COVID-19) vaccines: A concise review.
33978308 2021. Oral lesions postinjection of the first administration of Pfizer-BioNTech SARS-CoV-2 (BNT162b2) vaccine.
33844386 2021. An episode of oral mucositis after the first administration of the ChAdOx1 COVID-19 vaccine.
33844797 2021. Vacunas SARS CoV-2, estudios en fase III.
34108737 2021. Posible efecto del <> en la vacunacion frente a las nuevas variantes del SARS-CoV-2.
34108736 2021. Covid-19, guillain-barre y vacuna. Una mezcla peligrosa.
33994339 2021. Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19.
34103407 2021. Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection.
33931567 2021. Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose.
34103125 2021. La vaccination des soignants contre la Covid-19.
33962725 2021. Covid-19 et grippe : intention de vaccination chez les professionnels de sante.
34083026 2021. Atypical thrombosis associated with VaxZevria(R) (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres.
34049688 2021. Efficacy of COVID-19 vaccines: From clinical trials to real life.
33892936 2021. Thrombotic events after AstraZeneca vaccine: What if it was related to dysfunctional immune response?
33858693 2021. Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy.
33878469 2021. Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination.
34029848 2021. Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination.
34018389 2021. Dodsfall i sykehjem etter covid-19-vaksine.
33624982 2021. Koronavaksinering av kreftpasienter.
33928772 2021. Fatal hjerneblodning etter covid-19-vaksine.
33928773 2021. Dyp venetrombose mer enn to uker etter vaksinering mot covid-19.
33876625 2021. Private klinikker bor kunne sette covid-19-vaksiner.
34049359 2021. COVID-19 in Kidney Transplant Recipients Vaccinated With Oxford-AstraZeneca COVID-19 Vaccine (Covishield): A Single-center Experience From India.
33737163 2021. Blunting COVID-19's negative impact: Lessons from Israel's vaccination campaign.
34051353 2021. The story behind Chile's rapid rollout of COVID-19 vaccination.
34102015 2021. What gastroenterologists should know about SARS-CoV 2 vaccine: World Endoscopy Organization perspective.
33864857 2021. Low Rates of Urologic Side Effects Following Coronavirus Disease Vaccination: An Analysis of the Food and Drug Administration Vaccine Adverse Event Reporting System.
33846043 2021. Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study.
33846042 2021. The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety.
33888324 2021. Developing standard safety outcomes for COVID-19 vaccines.
33896663 2021. Ethics and execution of developing a 2nd wave COVID vaccine - Our interim phase I/II VSV-SARS-CoV2 vaccine experience.
34092431 2021. Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents.
34092429 2021. Myocarditis following COVID-19 mRNA vaccination.
34088506 2021. U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines.
34059373 2021. The first Chinese national standards for SARS-CoV-2 neutralizing antibody.
34039497 2021. An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose.
34070152 2021. A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques.
34069852 2021. Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants.
34067511 2021. Accidental Interruption of the Cold Chain for the Preservation of the Moderna COVID-19 Vaccine.
34067955 2021. The Incidence and Severity of Post-Vaccination Reactions after Vaccination against COVID-19.
34066016 2021. Mice Immunized with the Vaccine Candidate HexaPro Spike Produce Neutralizing Antibodies against SARS-CoV-2.
34064613 2021. Immune Response to COVID-19 mRNA Vaccine-A Pilot Study.
34068677 2021. Local Sustained GM-CSF Delivery by Genetically Engineered Encapsulated Cells Enhanced Both Cellular and Humoral SARS-CoV-2 Spike-Specific Immune Response in an Experimental Murine Spike DNA Vaccination Model.
33918841 2021. Strategies for Immunomonitoring after Vaccination and during Infection.
33918085 2021. Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis.
33918072 2021. Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines.
33916489 2021. The COVID-19 Vaccines: Recent Development, Challenges and Prospects.
33946748 2021. Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination.
33925650 2021. Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities-An Agent-Based Modeling Evaluation.
33925526 2021. An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times.
33864049 2021. COVID vaccines and blood clots: five key questions.
33854229 2021. India's COVID-vaccine woes - by the numbers.
33893760 2021. Messenger RNA Vaccines: Beckoning of a New Era in Cancer Immunotherapy.
33320052 2021. COVID-19 Vaccines May Not Prevent Nasal SARS-CoV-2 Infection and Asymptomatic Transmission.
33833099 2021. The story behind COVID-19 vaccines.
33888633 2021. Partial immunity and SARS-CoV-2 mutations-Response.
33888632 2021. Partial immunity and SARS-CoV-2 mutations.
33859017 2021. The dream vaccine.
33859010 2021. Vaccine link to serious clotting disorder firms up.
33971677 2021. Oxford-AstraZeneca ChAdOx1 COVID-19 Vaccine Does Not Alter Platelet Aggregation.
34049360 2021. Development of COVID-19 Infection in Transplant Recipients After SARS-CoV-2 Vaccination.
34028386 2021. Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept.
33966023 2021. Anti-SARS-CoV-2 T-cell Responses After mRNA Vaccination in Belatacept-treated Renal Transplant Patients.

33934060 2021. Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER).
34021394 2021. [(68)Ga]Ga-DOTA-TATE uptake due to COVID-19 vaccination.
33966088 2021. Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy.
34020833 2021. EBCOG position statement on COVID-19 vaccination for pregnant and breastfeeding women.
34097044 2021. Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization.
34061205 2021. The Combined Effect of Vaccination and Nonpharmaceutical Public Health Interventions-Ending the COVID-19 Pandemic.
34061203 2021. Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality.
33886507 2021. Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus.
33908897 2021. Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques.
33894163 2021. COVID-19 vaccines: building and maintaining confidence.
33887255 2021. Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma.
33977283 2021. COVID-19 vaccines in older adults with cancer: a Young International Society of Geriatric Oncology perspective.
34087093 2021. Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV.
33887209 2021. Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study.
34019801 2021. Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities.
34051181 2021. Vaccine development lessons between HIV and COVID-19.
34000242 2021. The rocky road to universal COVID-19 vaccination.
33887207 2021. COVID-19 herd immunity by immu" width="940" height="350" frameborder="0" scrolling="auto"></iframe> tion: are children in the herd?
33743847 2021. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study.
33930321 2021. Symptom study app provides real-world data on COVID-19 vaccines.
33930320 2021. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study.
33861968 2021. SARS-CoV-2 incidence and vaccine escape.
33357392 2021. Equitable distribution of COVID-19 vaccines.
33338440 2021. Concerns and motivations about COVID-19 vaccination.
34051887 2021. Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac.
33887210 2021. Recombinant protein vaccines against SARS-CoV-2.
33887208 2021. Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial.
33306980 2021. The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials.
33899038 2021. COVID-19 vaccine efficacy and effectiveness-the elephant (not) in the room.
33870240 2021. Serum sample neutralisation of BBIBP-CorV and ZF2001 vaccines to SARS-CoV-2 501Y.V2.
34087152 2021. COVID-19 mRNA vaccine-related adenopathy mimicking metastatic melanoma.
34087120 2021. COVID-19 vaccines in patients with cancer.
33930324 2021. Cancer and COVID-19 vaccines: a complex global picture.
33930323 2021. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.
33991482 2021. Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): a single-blind, parallel-group, randomised controlled trial.
33954296 2021. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications.
33870258 2021. Reply to "Focusing COVID-19 vaccinations on elderly and high-risk people".
33961878 2021. COVID-19 optimal vaccination policies: A modeling study on efficacy, natural and vaccine-induced immunity responses.
33915160 2021. Optimal allocation of limited vaccine to control an infectious disease: Simple analytical conditions.
34014913 2021. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021.
34014911 2021. Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties - United States, December 14, 2020-April 10, 2021.
34014909 2021. Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021.
33914723 2021. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021.
33914721 2021. Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members - Chicago, Illinois, December 2020-March 2021.
33914720 2021. COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program - Kentucky, March 2021.
33867582 2021. COVID-19-Impfstoffe fur Kinder und Jugendliche.
33867658 2021. Why are COVID-19 vaccines still in short supply?
33835769 2021. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
33835768 2021. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
33826816 2021. Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351).
33882219 2021. Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
33861525 2021. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.
33861524 2021. SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
33979486 2021. BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants.
33270381 2021. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.
33378609 2021. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
33378607 2021. A New Vaccine to Battle Covid-19.
33378605 2021. Maintaining Safety with SARS-CoV-2 Vaccines.
34099947 2021. Neuralgia amiotrofica secundaria a vacuna contra COVID-19 Vaxzevria (AstraZeneca).
34049738 2021. Recomendaciones diagnostico-terapeuticas del grupo de trabajo de expertos de FACME ad-hoc sobre el manejo de la trombosis venosa cerebral relacionada con la vacunacion frente a COVID-19.
33935343 2021. Sputnik V vaccine goes global.
33867618 2021. Covid-19 vaccines for kids.
33986292 2021. Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation.
33986287 2021. Protein-based antigen presentation platforms for nanoparticle vaccines.
33986272 2021. Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2.
33972565 2021. ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets.
33883557 2021. Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases.
33875658 2021. Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models.
33863911 2021. mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents.
33846340 2021. Force of infection: a determinant of vaccine efficacy?
33982646 2021. Problems associated with antiviral drugs and vaccines development for COVID-19: approach to intervention using expression vectors via GPI anchor.
33915546 2021. Vaccinating People with Obesity for COVID-19: EASO Call for Action.
33830447 2021. COVID-19 Vaccines: Special Considerations for the Obese Population.
33370015 2021. Coronavirus Disease 2019 (COVID-19) Vaccines and Pregnancy: What Obstetricians Need to Know.
33839780 2021. Do Corticosteroid Injections for the Treatment of Pain Influence the Efficacy of Adenovirus Vector-Based COVID-19 Vaccines?
33933145 2021. Review the safety of Covid-19 mRNA vaccines: a review.
33828922 2021. Immunoinformatic approach to design a multiepitope vaccine targeting non-mutational hotspot regions of structural and non-structural proteins of the SARS CoV2.
33909687 2021. Potential impact of introducing vaccines against COVID-19 under supply and uptake constraints in France: A modelling study.
33886573 2021. The impact of COVID-19 vaccination campaigns accounting for antibody-dependent enhancement.
33882114 2021. Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization.
34014316 2021. Bell's palsy following the Ad26.COV2.S COVID-19 vaccination.
33985514 2021. Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle?
34058573 2021. Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine.
33875266 2021. The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial.
34020815 2021. Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines.
34006408 2021. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).
34049734 2021. Covid-19 vaccine trials: Ethnic diversity and immunogenicity.
34023137 2021. Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests.
33339671 2021. Critical aspects of packaging, storage, preparation, and administration of mRNA and adenovirus-vectored COVID-19 vaccines for optimal efficacy.
33485647 2021. The economics of global COVID vaccine administration during a pandemic - Why continue skin alcohol preparation as a costly but ineffective practice?
33836897 2021. COVID-19 vaccine safety questions and answers for healthcare providers (CONSIDER).
33824043 2021. The development of COVID-19 vaccines in the United States: Why and how so fast?
33824042 2021. Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naive BNT162b2 vaccine recipients.
33958223 2021. Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia.
34067141 2021. Sensitivity to COVID-19 Vaccine Effectiveness and Safety in Shanghai, China.
34066475 2021. Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
34066443 2021. Probiotic-Based Vaccines May Provide Effective Protection against COVID-19 Acute Respiratory Disease.
34063733 2021. Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2.
34063562 2021. Rotavirus as an Expression Platform of Domains of the SARS-CoV-2 Spike Protein.
33925446 2021. A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold Response.
33923363 2021. Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups.
33919151 2021. Allergy to Polyethilenglicole of Anti-SARS CoV2 Vaccine Recipient: A Case Report of Young Adult Recipient and the Management of Future Exposure to SARS-CoV2.
33921677 2021. AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate.
33923573 2021. Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles.
33923530 2021. Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database.
33921215 2021. The C-Terminal Domain of Nef(mut) Is Dispensable for the CD8(+) T Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles.
33916222 2021. Factors Influencing the Efficacy of COVID-19 Vaccines: A Quantitative Synthesis of Phase III Trials.
33916180 2021. A Whole Virion Vaccine for COVID-19 Produced via a Novel Inactivation Method and Preliminary Demonstration of Efficacy in an Animal Challenge Model.
33915773 2021. BNT162b2 Vaccine Encoding the SARS-CoV-2 P2 S Protects Transgenic hACE2 Mice against COVID-19.
33915696 2021. Dissolvable Microneedle Patches to Enable Increased Access to Vaccines against SARS-CoV-2 and Future Pandemic Outbreaks.
33875919 2021. Los gobiernos y la vacunacion contra la COVID-19.
33867900 2021. Impacto de las variantes geneticas de la espicula en las vacunas frente al SARS-CoV-2.

34092181 2021. Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants.
34003073 2021. Mining of linear B cell epitopes of SARS-CoV-2 ORF8 protein from COVID-19 patients.
33993845 2021. Prime-boost vaccination of mice and rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates.
33890550 2021. A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters.
33913314 2021. Potential culprits for immediate hypersensitivity reactions to BNT162b2 mRNA COVID-19 vaccine: not just PEG.
33939345 2021. Lessons from peculiar cases of anaphylaxis: why allergists should be prepared for the unexpected.
33855628 2021. Appropriateness for SARS-CoV-2 vaccination for otolaryngologist and head and neck surgeons in case of pregnancy, breastfeeding, or childbearing potential: Yo-IFOS and CEORL-HNS joint clinical consensus statement.
34095746 2021. COVID-19 vaccination may cause FDG uptake beyond axillary area.
33966930 2021. SARS-CoV-2 vaccines: Lights and shadows.
34092488 2021. Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines.
34090750 2021. SARS-CoV-2 vaccine-induced cerebral venous thrombosis.
34001390 2021. The importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination.
33937467 2021. Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: Report of 5 cases.
33898675 2021. New-onset chilblains in close temporal association to mRNA-1273 vaccination.
34056055 2021. A case of severe cutaneous adverse reaction following administration of the Janssen Ad26.COV2.S COVID-19 vaccine.
33997209 2021. Widespread annular eruption after Ad26.COV2.S COVID-19 vaccine.
33958175 2021. Acute Coronary Tree Thrombosis After Vaccination for COVID-19.
33835172 2021. Public Perspectives on COVID-19 Vaccine Prioritization.
33892859 2021. Answering the call to action: rapid implementation of an in-center hemodialysis SARS-CoV-2 vaccination program.
33931226 2021. Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy.
33887320 2021. Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won.
33887318 2021. Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients.
33887316 2021. Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms.
33887315 2021. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine.
33932459 2021. Acute rejection after anti-SARS-CoV-2 mRNA vaccination in a patient who underwent a kidney transplant.
33932458 2021. A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination.
34087252 2021. Gross hematuria following SARS-CoV-2 vaccination in patients with IgA nephropathy.
34081948 2021. ANCA glomerulonephritis after the Moderna COVID-19 vaccination.
34081947 2021. Humoral response of the mRNA-1273 SARS-CoV-2 vaccine in peritoneal dialysis patients.
34052236 2021. Letter regarding "Minimal change disease relapse following SARS-CoV-2 mRNA vaccine".
34048824 2021. Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine.
34033857 2021. Is COVID-19 vaccination unmasking glomerulonephritis?
34029554 2021. Occurrence of severe COVID-19 in vaccinated transplant patients.
34000278 2021. Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine.
33992674 2021. Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination.
33964312 2021. Minimal change disease relapse following SARS-CoV-2 mRNA vaccine.
34027513 2021. Can integrated post-exposure vaccination against SARS-COV2 mitigate severe disease?
33895650 2021. Deaths associated with newly launched SARS-CoV-2 vaccination (Comirnaty(R)).
33986431 2021. COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia.
34023850 2021. Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms.
33942763 2021. Unilateral lymphadenopathy after COVID-19 vaccination.
33975938 2021. An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines.
33966881 2021. Antecedentes personales y vacunales como factores asociados a la infeccion por SARS-CoV-2.
33836858 2021. La vacunacion de la COVID-19.
34092400 2021. Hemorragias acrales tras la administracion de la segunda dosis de la vacuna contra el SARS-CoV-2. inverted question markUna reaccion posvacunal?
34034917 2021. Reflexiones medico-legales, eticas y deontologicas de la vacunacion de COVID-19 en profesionales sanitarios.
33317876 2021. Relacion entre la gravedad de la infeccion Covid-19 y el estado vacunal. Resultados de una encuesta anonima entre medicos de atencion primaria.
33942804 2021. Editorial: mRNA Vaccines and Future Epidemic, Pandemic, and Endemic Zoonotic Virus Infections.
33900279 2021. Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT).
33952256 2021. Immune response induced by oral administration with a Saccharomyces cerevisiae-based SARS-CoV-2 vaccine in mice.
34022375 2021. Development of leading first-generation vaccines against SARS-CoV-2.
34065996 2021. An Intramuscular DNA Vaccine for SARS-CoV-2 Decreases Viral Lung Load but Not Lung Pathology in Syrian Hamsters.
33851711 2021. Anaphylaxis After the Covid-19 Vaccine in a Patient With Cholinergic Urticaria.
33956784 2021. Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021.
33956782 2021. Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged >/=65 Years - United States, January-March 2021.
33956781 2021. Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021.
34043615 2021. COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021.
34058986 2021. Heterologous vaccine interventions: boosting immunity against future pandemics.
34022793 2021. Possible inhibition of GM-CSF production by SARS-CoV-2 spike-based vaccines.
33840183 2021. Gender differences in vaccine therapy: where are we in COVID-19 pandemic?
33856242 2021. COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021.
34049216 2021. Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis.
33990054 2021. COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab.
33883063 2021. B cell therapy and the use of RNA-based COVID-19 vaccines.
33951374 2021. Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
33852795 2021. Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination.
33826815 2021. Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2.
33882218 2021. Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.
33826819 2021. Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351.
33951357 2021. Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.
34010526 2021. Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents.
34043894 2021. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
33730471 2021. Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.
34075212 2021. SARS-CoV-2 variants, spike mutations and immune escape.
34025046 2021. Impfung gegen SARS-CoV-2 bei Krebspatienten.
33936526 2021. A Data Driven Approach for Prioritizing COVID-19 Vaccinations in the Midwestern United States.
34056031 2021. SARS-CoV-2 Vaccination During Pregnancy: A Complex Decision.
34076928 2021. COVID-19 vaccination in pediatric solid organ transplant recipients-Current state and future directions.
33858942 2021. Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model.
34019911 2021. Covid-19 vaccine- induced thrombosis and thrombocytopenia-a commentary on an important and practical clinical dilemma.
33909239 2021. Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine.
33986880 2021. Position statement of the Polish Society of Gastroenterology and the National Gastroenterology Consultant on vaccination against COVID-19 among patients with inflammatory bowel diseases.
33871650 2021. Carnitine palmitoyltransferase II deficiency and post-COVID vaccination rhabdomyolysis.
33968285 2021. COVID-19 vaccine induced Axillary and Pectoral Lymphadenopathy on PET scan.
33868525 2021. Unilateral axillary lymphadenopathy following COVID-19 vaccination: A case report and imaging findings.
34025885 2021. Myocarditis following COVID-19 vaccination.
33874733 2021. COVID-19 Vaccination-Related Lymphadenopathy: What To Be Aware Of.
33904778 2021. Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination.
33780329 2021. COVID-19 and Treatment and Immunization of Children-The Time to Redefine Pediatric Age Groups is Here.
33942008 2021. In vitro cell culture model of human nasal-associated lymphoid tissue (NALT) to evaluate the humoral immune response to SARS-CoV-2 spike proteins.
33372339 2021. Talk of the town in 2021: Covid-19 vaccines likely take centre stage.
34039746 2021. SARS-CoV-2 vaccination of people living with human T leukaemia virus type 1.
34059617 2021. A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity.
34023862 2021. SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern.
34006829 2021. COVID-19 vaccines: progress and understanding on quality control and evaluation.
33944967 2021. Subacromial-subdeltoid bursitis following COVID-19 vaccination: a case of shoulder injury related to vaccine administration (SIRVA).
34022491 2021. Comorbid insomnia and sleep apnea (COMISA) as an additional risk factor for reduced response to the COVID-19 vaccination?
34104221 2021. Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.
34104219 2021. Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.
34035836 2021. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.
33898273 2021. Safety of COVID-19 vaccines administered in the EU: Should we be concerned?
33888416 2021. Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine.
33971319 2021. COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors.
34051352 2021. Emerging issues in COVID-19 vaccination in tropical areas: Impact of the immune response against helminths in endemic areas.
34013223 2021. Coronavirus infections in childhood and vaccine studies.
33925069 2021. Identification of Highly Conserved SARS-CoV-2 Antigenic Epitopes with Wide Coverage Using Reverse Vaccinology Approach.
33847296 2021. Commentary: Perinatal Coronavirus Disease 2019 and Maternal Vaccination: What More Do We Need to Know?
34077949 2021. Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine.
34088762 2021. Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination.
34088761 2021. Myocarditis After SARS-CoV-2 Vaccination: True, True, and... Related?
33980697 2021. COVID-19 Vaccines in Children and Adolescents.
34049881 2021. Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates.

33355178 2021. Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited.
34029956 2021. Coordination and optimization of FDG PET/CT and COVID-19 vaccination; Lessons learned in the early stages of mass vaccination.
34007056 2021. SARS-CoV-2 vaccines: anamnestic response in previously infected recipients.
33321075 2021. Predicted Cellular Immunity Population Coverage Gaps for SARS-CoV-2 Subunit Vaccines and Their Augmentation by Compact Peptide Sets.
33928916 2021. Immunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults: randomized, double-blind, and placebo-controlled phase 1 and phase 2 clinical trials.
33937733 2021. SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy.
34095793 2021. Association between previous infection with SARS CoV-2 and the risk of self-reported symptoms after mRNA BNT162b2 vaccination: Data from 3,078 health care workers.
33319186 2021. The challenges of distributing COVID-19 vaccinations.
33830018 2021. Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection.
33829462 2021. SARS-CoV-2 vaccine development: where are we?
33877041 2021. COVID-19 Vaccine Concerns: Fact or Fiction?
33896316 2021. The emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines?
33929930 2021. Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China.
33851875 2021. Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies.
34095871 2021. SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility.
33901607 2021. SARS-CoV-2 inactivated vaccine (Vero cells) shows good safety in repeated administration toxicity test of Sprague Dawley rats.
33996868 2021. COVID-19 and Sarcoidosis, Readiness for Vaccination: Challenges and Opportunities.
33968996 2021. Antibodies and Vaccines Target RBD of SARS-CoV-2.
33959636 2021. Impact of Ribosome Activity on SARS-CoV-2 LNP - Based mRNA Vaccines.
33937326 2021. Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19.
33869282 2021. Perspectives on RNA Vaccine Candidates for COVID-19.
34035759 2021. Vaccination of Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic.
34035758 2021. The Importance of Vaccinating IBD Patients During the COVID-19 Pandemic.
34048782 2021. Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications.
34029569 2021. AGA Rapid Review and Guideline for SARS-CoV2 Testing and Endoscopy Post-Vaccination: 2021 Update.
34015337 2021. COVID-19 Vaccination and IBD: Desired antibody responses, future directions, and a note of caution.
33887219 2021. Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies.
34079091 2021. Gene therapy avenues and COVID-19 vaccines.
34040942 2021. WHF Position Statement on COVID Vaccination.
34080997 2021. Covid-19 vaccine trials and ethics: Protection delayed is protection denied.
34080991 2021. Emergency use authorisation of Covid-19 vaccines: An ethical conundrum.
34080989 2021. Covid-19 vaccines: The public must have confidence in the science.
33845947 2021. Covid-19 vaccines and new mutant strains impacting the pandemic.
33934742 2021. Effect of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) mRNA vaccination in healthcare workers with high-risk coronavirus disease 2019 (COVID-19) exposure.
34039450 2021. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in vaccinated and unvaccinated healthcare personnel in a Veterans' Affairs healthcare system.
33858531 2021. Coronavirus disease 2019 (COVID-19) vaccination in healthcare workers: An early real-world experience.
33853695 2021. An assessment of the impact of the vaccination program on coronavirus disease 2019 (COVID-19) outbreaks in care homes in Northern Ireland-A pilot study.
33932192 2021. Brief review of the mRNA vaccines COVID-19.
33898733 2021. Immunoinformatics and molecular modeling approach to design universal multi-epitope vaccine for SARS-CoV-2.
33895475 2021. Potential SARS-CoV-2 vaccines: Concept, progress, and challenges.
33907509 2021. Review of Covid-19 vaccine clinical trials - A puzzle with missing pieces.
33907508 2021. mRNA vaccines for COVID-19: what, why and how.
33907443 2021. Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study.
33872783 2021. First case of postmortem study in a patient vaccinated against SARS-CoV-2.
33897313 2021. Prediction of Epitope based Peptides for Vaccine Development from Complete Proteome of Novel Corona Virus (SARS-COV-2) Using Immunoinformatics.
33839230 2021. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability.
33964339 2021. Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines?
33978550 2021. Tapping the immunological imprints to design chimeric SARS-CoV-2 vaccine for elderly population.
34021862 2021. Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights.
34100214 2021. Immune thrombocytopenia following COVID-19 mRNA vaccine: casuality or causality?
34046690 2021. Impfstoffentwicklung zur Pravention von COVID-19 - Teil 3.
33355681 2021. Impfstoffentwicklung zur Pravention von COVID-19.
34041693 2021. Impact of first dose of BNT162b2 vaccine on COVID-19 infection among healthcare workers in an Irish hospital.
33960748 2021. SARS-CoV-2 vaccines and biological treatments: dermatological perspectives.
33960747 2021. Adverse cutaneous and mucous reactions from anti SARS-CoV-2 vaccines: recommendations from the Italian Society of Dermatology (SIDeMaST).
34087242 2021. Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity.
34052265 2021. Optimizing investigation of suspected allergy to polyethylene glycols.
33857566 2021. Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines.
34033981 2021. Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome.
34051613 2021. Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
34020254 2021. Perspectives on vaccine induced thrombotic thrombocytopenia.
33984571 2021. A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine.
34098950 2021. Identification of COVID-19 B-cell epitopes with phage-displayed peptide library.
34038700 2021. Engineering a multi epitope vaccine against SARS-CoV-2 by exploiting its non structural and structural proteins.
34032357 2021. Immunogenicity and safety of BNT162b2 COVID-19 vaccine in a chronic lymphocytic leukaemia patient.
33325143 2021. T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research.
34048910 2021. Randomized COVID-19 vaccination rollout can offer direct real-world evidence.
33974565 2021. What should define a SARS-CoV-2 "breakthrough" infection?
33956667 2021. One dose of SARS-CoV-2 vaccine exponentially increases antibodies in individuals who have recovered from symptomatic COVID-19.
33939647 2021. First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19.
33945504 2021. Is complement the culprit behind COVID-19 vaccine-related adverse reactions?
34101623 2021. Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients.
34101621 2021. The Israeli study of Pfizer BNT162b2 vaccine in pregnancy: considering maternal and neonatal benefits.
33918932 2021. Thrombocytopenia and Intracranial Venous Sinus Thrombosis after "COVID-19 Vaccine AstraZeneca" Exposure.
33916020 2021. Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic.
34007358 2021. Review of COVID-19 Vaccines Approved in the United States of America for Emergency Use.
34077622 2021. Herpes zoster after inactivated COVID-19 vaccine: A cutaneous adverse effect of the vaccine.
33941502 2021. COVID-19 vaccine prioritisation for people with cystic fibrosis.
34077690 2021. COVID-19: Seroprevalence and Vaccine Responses in UK Dental Care Professionals.
34062184 2021. Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination.
33933530 2021. Early observations on the impact of a healthcare worker COVID-19 vaccination programme at a major UK tertiary centre.
33852930 2021. Asymptomatic COVID-19 cases among older patients despite BNT162b2 vaccination: A case series in a geriatric rehabilitation ward during an outbreak.
34052241 2021. Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination.
34044037 2021. Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India.
34060264 2021. Positivity of SARS-CoV-2 Antibodies among Korean Healthy Healthcare Workers 1 and 2 Weeks after Second Dose of Pfizer-BioNTech Vaccination.
34060261 2021. Adverse Reactions of the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers in Korea.
33942579 2021. Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea.
33942578 2021. Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System.
33975397 2021. Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?
33876589 2021. Early Safety Monitoring of COVID-19 Vaccines in Healthcare Workers.
33847085 2021. Adverse Events in Healthcare Workers after the First Dose of ChAdOx1 nCoV-19 or BNT162b2 mRNA COVID-19 Vaccination: a Single Center Experience.
34040784 2021. We should not vaccinate the young to protect the old: a response to Giubilini, Savulescu, and Wilkinson.
33967342 2021. In silico identification of RBD subdomain of spike protein from Pro(322)-Thr(581) for applications in vaccine development against SARS-CoV2.
33632278 2021. Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers.
34050904 2021. Immunogenicity of a first dose of mRNA- or vector-based SARS-CoV-2 vaccination in dialysis patients: a multicenter prospective observational pilot study.
33342640 2021. COVID-19 Vaccines for Children: The Essential Role of the Pediatric Nurse.
34035689 2021. Importance of Pediatric Studies in SARS-CoV-2 Vaccine Development.
33912506 2020. The COVID-19 Vaccine Saga: A Perspective.
33993119 2021. Canadian Rheumatology Association Recommendation for the Use of COVID-19 Vaccination for Patients With Autoimmune Rheumatic Diseases.
34057463 2021. High immunogenicity of a messenger RNA based vaccine against SARS-CoV-2 in chronic dialysis patients.
33999200 2021. Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared to healthy controls.
34109386 2021. Myositis ossificans following COVID-19 vaccination.
34109037 2021. The trade-off between mobility and vaccination for COVID-19 control: a metapopulation modelling approach.
34108440 2021. Fast-spreading SARS-CoV-2 variants: challenges to and new design strategies of COVID-19 vaccines.
33991580 2021. Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in patients with PEG allergy.
34042415 2021. Phageome-based vaccination and human innate immune modulation could be a useful strategy to control human Coronavirus infections.
33377359 2021. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
33998976 2021. COVID-19 vector-based vaccine causing thrombosis.
34089016 2021. Six months of COVID vaccines: what 1.7 billion doses have taught scientists.
34038554 2021. The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis, or living with a kidney transplant - a prospective, controlled, multicenter observational cohort by the REnal patients COVID-19 VACcination (RECOVAC) consortium COVID-19 VACcination (RECOVAC) consortium.
33944757 2021. COVID-19 vaccination: Recommendations for management of patients with allergy or immune-based diseases.
33833104 2021. Latest Russian vaccine comes with a big dose of mystery.

33958344 2021. Thrombotic thrombocytopenia due to SARS-CoV-2 vaccination.
34060379 2021. An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination.
34036839 2021. Spotlight on Adenovirus-Based Vaccines and Rare Thrombotic Events.
33872607 2021. Methods matter - Tailoring SARS-CoV-2 antibody targets to vaccination status.
33857476 2021. Antibody response to first and second dose of BNT162b2 in a cohort of characterized healthcare workers.
33838977 2021. Re: Unilateral axillary adenopathy in the setting of COVID-19 vaccine, Clinical Imaging, January 2021.
33932618 2021. Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation.
34089859 2021. Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus.
33949653 2021. COVID-19 Vaccines Have Moved Out of Neutral, but Still Gearing Up in Children.
33704435 2021. Impact of the COVID-19 Vaccine on Asymptomatic Infection Among Patients Undergoing Pre-Procedural COVID-19 Molecular Screening.
33977301 2021. Adults Hospitalized With Coronavirus Disease 2019 (COVID-19)-United States, March-June and October-December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes.
33825869 2021. Humoral and cellular immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in nursing home residents.
33825859 2021. SARS-CoV-2 outbreak in a long-term care facility after vaccination with BNT162b2.
33975007 2021. Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2).
33957273 2021. Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study.
33928459 2021. Coronavirus disease 2019 (COVID-19) vaccination in systemic lupus erythematosus and anti-neutrophil cytoplasmic antibody-associated vasculitis.
34045122 2021. COVID-19 Vaccine Effectiveness.
34039479 2021. Exploration and Ethical Analysis of Open-label Pediatric Vaccine Trials in a Pandemic.
33832783 2021. The Next Set of COVID-19 Vaccines: Leveraging New Development Platforms to Increase Access for More People Around the World.
34007835 2021. PET findings after COVID-19 vaccination: "Keep Calm and Carry On".
33841880 2021. Preclinical development of a molecular clamp-stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2.
34047471 2021. Identification of potential vaccine targets for COVID-19 by combining single-cell and bulk TCR sequencing.
33980499 2021. Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis.
34001557 2021. Grossesse, allaitement et vaccin contre le SRAS-CoV-2 : cadre ethique pour la prise de decision partagee.
33990339 2021. Limb ischemia and pulmonary artery thrombosis afer the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine: a case of vaccine-induced immune thrombotic thrombocytopenia.
33936564 2021. An overview of current COVID-19 vaccine platforms.
33845870 2021. Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19.
33834172 2021. Prolonged Anaphylaxis to Pfizer Coronavirus Disease 2019 Vaccine: A Case Report and Mechanism of Action.
33968543 2021. A Case of Postural Orthostatic Tachycardia Syndrome Secondary to the Messenger RNA COVID-19 Vaccine.
33927933 2021. COVID-19 Vaccine and Hyperosmolar Hyperglycemic State.
33867863 2021. Status Report on COVID-19 Vaccines Development.
34073214 2021. Ethical Considerations in Chemotherapy and Vaccines in Cancer Patients in Times of the COVID-19 Pandemic.
34093062 2021. Opportunities for innovation: Building on the success of lipid nanoparticle vaccines.
33906124 2021. Future considerations for the mRNA-lipid nanoparticle vaccine platform.
34049261 2021. SARS-CoV-2 vaccines - the biggest medical research project of the 21st century.
33969163 2021. Survey data of COVID-19 vaccine side effects among hospital staff in a national referral hospital in Indonesia.
33918702 2021. Immune Response Visualized In Vivo by [18F]-FDG PET/CT after COVID-19 Vaccine.
33941488 2021. Italian association for the study of the liver position statement on SARS-CoV2 vaccination.
33963055 2021. SARS-CoV-2 Spike Protein Stabilized in the Closed State Induces Potent Neutralizing Responses.
33993619 2021. Steroid-Resistant Acute Cellular Rejection of the Liver After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination.
34098108 2021. Comparative immunogenicity analysis of intradermal versus intramuscular administration of SARS-CoV-2 RBD epitope peptide-based immunogen In vivo.
33983745 2021. The Possible Role of Sex As an Important Factor in Development and Administration of Lipid Nanomedicine-Based COVID-19 Vaccine.
33352107 2021. Innate Inhibiting Proteins Enhance Expression and Immunogenicity of Self-Amplifying RNA.
34091054 2021. Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNP.
34015254 2021. Low-dose single-shot COVID-19 mRNA vaccines lie ahead.
33895322 2021. Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19.
33684280 2021. Neutralizing Activity of BNT162b2-Elicited Serum.
33973802 2021. How has nanomedical innovation contributed to the COVID-19 vaccine development?
34001897 2021. Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice.
34103510 2021. Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination.
33824489 2021. Emerging concepts in the science of vaccine adjuvants.
33927376 2021. Will SARS-CoV-2 variants of concern affect the promise of vaccines?
33340022 2021. Viral targets for vaccines against COVID-19.
33868742 2021. Development and implementation of a potential coronavirus disease 2019 (COVID-19) vaccine: A systematic review and meta-analysis of vaccine clinical trials.
33944946 2021. COVID-19 and ANCA-associated vasculitis - recommendations for vaccine preparedness and the use of rituximab.
33895831 2021. Efficacy of the BNT162b2 mRNA Covid-19 Vaccine in a hemodialysis cohort.
33839785 2021. Antibody response to mRNA SARS-CoV-2 vaccine among dialysis patients - a prospectivecohort study.
33907627 2021. Is the heparin-induced thrombocytopenia-like syndrome associated with ChAdOx vaccine related to the vaccine itself or to an autoimmune reaction to severe acute respiratory syndrome 2 coronavirus: insights and implications from previous reports in infected cases?
34092876 2021. Is it safe to breastfeed my baby after a coronavirus vaccine?
34024981 2021. Are booster shots coming?
34069575 2021. Immunogenicity of Adjuvanted Psoralen-Inactivated SARS-CoV-2 Vaccines and SARS-CoV-2 Spike Protein DNA Vaccines in BALB/c Mice.
33923054 2021. COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials.
34075293 2021. Expediting COVID-19 vaccination increases QALYs and saves costs in the USA.
33882066 2021. Evaluation of COVID-19 vaccination strategies with a delayed second dose.
33956791 2021. Modelling optimal vaccination strategy for SARS-CoV-2 in the UK.
34043618 2021. DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss.
33906339 2021. Vacunacion anti-COVID-19: La realidad tras los ensayos clinicos.
33913444 2021. Efectividad de la primera dosis de vacuna BNT162b2 para prevenir la COVID-19 en personal sanitario.
33848321 2021. Herpes zoster following BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series.
33858945 2021. Distinct antibody and memory B cell responses in SARS-CoV-2 naive and recovered individuals following mRNA vaccination.
33828130 2021. Cytotoxic T-lymphocyte elicited vaccine against SARS-CoV-2 employing immunoinformatics framework.
34072058 2021. SARS-CoV-2 Vaccination and Anaphylaxis: Recommendations of the French Allergy Community and the Montpellier World Health Organization Collaborating Center.
34071883 2021. Thrombotic Thrombocytopenia after COVID-19 Vaccination: In Search of the Underlying Mechanism.
34073382 2021. Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects.
34070671 2021. Pfizer-BioNTech COVID-19 Vaccine Tolerance in Allergic versus Non-Allergic Individuals.
33843419 2021. Women perception of SARS-CoV-2 vaccination during pregnancy and subsequent maternal anxiety: a prospective observational study.
33840294 2021. Review of COVID-19 mRNA Vaccines: BNT162b2 and mRNA-1273.
33843975 2021. SARS-CoV-2-Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women.
33974012 2021. Even Partial COVID-19 Vaccination Protects Nursing Home Residents.
33956050 2021. Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce.
33956048 2021. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
33929487 2021. US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.
33983379 2021. Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women.
33950155 2021. Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.
34037666 2021. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial.
33315080 2021. The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
33315069 2021. Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.
33978670 2021. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series.
33999120 2021. Efficacy of COVID-19 Vaccines Against Active Comparators or Inert Placebos.
33904857 2021. Association of Facial Paralysis With mRNA COVID-19 Vaccines: A Disproportionality Analysis Using the World Health Organization Pharmacovigilance Database.
33897043 2021. Note of the Congregation for the Doctrine of the Faith on the morality of using some anti-Covid-19 vaccines, 21.12.2020.
33836419 2021. Are prion proteins and magnetite involved in the immune cells memory system connected to the covid-19?
33976102 2021. In brief: Johnson & Johnson COVID-19 vaccine suspended.
33976095 2021. In brief: Suspension of Johnson & Johnson COVID-19 vaccine lifted.
33976088 2021. FDA authorizes Johnson & Johnson COVID-19 vaccine.
34080537 2021. COVID-19, des vaccins a la vitesse de l'eclair.
33295677 2021. Prediction of putative epitope-based vaccine against all corona virus strains for the Chinese population: Approach toward development of vaccine.
33882227 2021. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply.
33882226 2021. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
33979495 2021. Audio Interview: Vaccination and Variants in the U.S. and South Africa.
34077642 2021. Vaccine Breakthrough Infections with SARS-CoV-2 Variants. Reply.
34077641 2021. Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
34077640 2021. Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
33979508 2021. More on SARS-CoV-2 Infection after Vaccination in Health Care Workers. Reply.
33979507 2021. More on SARS-CoV-2 Infection after Vaccination in Health Care Workers.
33277624 2021. COVID-19 vaccines buoy hope.
34021284 2021. Scientists zero in on long-sought marker of COVID-vaccine efficacy.
34002079 2021. COVID vaccines can block variant hitting Asia, lab study finds.
33986508 2021. Delaying a COVID vaccine's second dose boosts immune response.
33976411 2021. Mice with severe COVID symptoms could speed vaccine effort.
33971664 2021. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses.
34044428 2021. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.

34021048 2021. Influenza Virus and SARS-CoV-2 Vaccines.
33972374 2021. Cellular and Humoral Immune Responses in Mice Immunized with Vaccinia Virus Expressing the SARS-CoV-2 Spike Protein.
33873199 2021. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.
33260195 2021. A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate.
33927405 2021. Can Cuba beat COVID with its homegrown vaccines?
33864047 2021. Coronapod: could COVID vaccines cause blood clots? Here's what the science says.
34097667 2021. COVID-19 Vaccination Outcomes at a Pediatric Long-Term Care Facility.
33998197 2021. Innocuite du vaccin a ARNm Covid-19 chez les femmes enceintes : resultats preliminaires.
33830701 2021. Vaccins contre le Covid-19 : cibles vaccinales, immunogenicite et reactions allergiques.
33852214 2021. Reponses immunes a une dose de vaccin administree apres un Covid.
33896793 2021. Interim statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on vaccine safety on AstraZeneca COVID-19 vaccine.
33766863 2021. New problems erode confidence in AstraZeneca's vaccine.
33766861 2021. Volatility of vaccine confidence.
33915005 2021. SARS-CoV-2 infection after two doses of mRNA vaccine in renal transplant recipients.

33893480 2021. First dose of BNT162b2 mRNA vaccine in a Health Care Worker cohort is associated with reduced symptomatic and asymptomatic SARS-CoV-2 infection.
33953551 2021. Considering Frailty in SARS-CoV-2 Vaccine Development: How Geriatricians Can Assist.
33930764 2021. Immunogenomics guided design of immunomodulatory multi-epitope subunit vaccine against the SARS-CoV-2 new variants, and its validation through in silico cloning and immune simulation.
33895459 2021. Exploring SARS-COV-2 structural proteins to design a multi-epitope vaccine using immunoinformatics approach: An in silico study.
33969180 2021. First COVID-19 Vaccines Receiving the US FDA and EMA Emergency Use Authorization.
33993417 2021. Mucosal and transdermal vaccine delivery strategies against COVID-19.
33826439 2021. Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines.
33976529 2021. COVID-19 vaccination in pregnancy.
33913552 2021. Lack of immune response after mRNA vaccination to SARS-CoV-2 in a solid organ transplant patient.
33913545 2021. Herpes zoster emergence following mRNA COVID-19 vaccine.
33851735 2021. Bioinformatics and immunoinformatics to support COVID-19 vaccine development.
33822361 2021. Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: A randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms.
33788281 2021. Antibody response to SARS-CoV-2 vaccination is extremely vivacious in subjects with previous SARS-CoV-2 infection.
33882225 2021. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
34007070 2021. Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19.
33864052 2021. Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy.
34040262 2021. Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2.
33675239 2021. Nucleoside-modified messenger RNA COVID-19 vaccine platform.
33973833 2021. Mass population vaccination for COVID-19 in Malta.
34014263 2021. Preliminary Analysis of Association Between COVID-19 Vaccination and Sudden Hearing Loss Using US Centers for Disease Control and Prevention Vaccine Adverse Events Reporting System Data.
34086047 2021. Children and COVID-19 Vaccines.
33975372 2021. Eine akute Fazialisparese als mogliche Impfkomplikation bei einer Impfung gegen SARS-CoV-2.
34044465 2021. COVID-19-Impfungen: Replizierend oder Nichtreplizierend?
33909962 2021. Beyond the First Dose - Covid-19 Vaccine Follow-through and Continued Protective Measures.
33826826 2021. Audio Interview: Antibody Responses to Natural Infection and Vaccination.
33913647 2021. Audio Interview: Advice for Clinicians on Covid-19 Vaccines and Social Restrictions.
33761227 2021. Leveraging Open Science to Accelerate Research.
33882211 2021. Audio Interview: Covid-19 Vaccines and Pregnancy - A Conversation with CDC Director Rochelle Walensky.
33852785 2021. Audio Interview: Vaccine Successes and Vaccine Adverse Events.
33927434 2021. Challenge for COVID-19 vaccines to protect the New Zealand population.
34032435 2021. Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 Infection.
34060925 2021. Vaccine Strategy During the SARS-CoV-2 Pandemic: What School Nurses Need to Know.
33981074 2021. A network analysis of COVID-19 mRNA vaccine patents.
34059823 2021. After COVID-19 successes, researchers push to develop mRNA vaccines for other diseases.
33903751 2021. Being fair to participants in placebo-controlled COVID-19 vaccine trials.
33888900 2021. Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study.
33875890 2021. COVID-19 dynamics after a national immunization program in Israel.
33335323 2021. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
33335322 2021. Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.
33927396 2021. COVID-19 vaccine and blood clotting.
34117206 2021. A 59-Year-Old Woman with Extensive Deep Vein Thrombosis and Pulmonary Thromboembolism 7 Days Following a First Dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.
34171719 2021. Cardiac arrest secondary to Covid19 pneumonia post full vaccination.
34133027 2021. Cerebral venous thrombosis post BNT162b2 mRNA SARS-CoV-2 vaccination: A black swan event.
34185336 2021. BNT162b2 COVID-19 vaccine is significantly less effective in patients with hematologic malignancies.
34112654 2021. Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'.
34133951 2021. Seroconversion rates following COVID-19 vaccination among patients with cancer.
34142647 2021. Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021.
34172912 2021. Orofacial adverse effects of COVID-19 vaccines exist but are rare.
34108961 2021. Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model.
34093567 2021. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.
34123969 2021. Mandatory Infant Vaccinations in France During the COVID-19 Pandemic in 2020.
34109900 2021. SARS-CoV-2: Unique Challenges of the Virus and Vaccines.
34162141 2021. An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages.
34138513 2021. Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia.
34155756 2021. Medical Oncology Group of Australia position statement: COVID-19 vaccination in patients with solid tumours.
34174156 2021. Hyaluronic acid soft tissue filler delayed inflammatory reaction following COVID-19 vaccination - A case report.
34167874 2021. Clinical and histopathological views of morbilliform rash after COVID-19 mRNA vaccination mimic those in SARS-CoV-2 virus infection-associated cutaneous manifestations.
34143368 2021. Minimal change disease following vaccination for SARS-CoV-2.
34182207 2021. A case of longitudinally extensive transverse myelitis following vaccination against Covid-19.
34153802 2021. New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine.
34115170 2021. First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine.
34120504 2021. COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as Cellulitis.
34171649 2021. Vaccine-Induced Immune Thrombotic Thrombocytopenia with Disseminated Intravascular Coagulation and Death following the ChAdOx1 nCoV-19 Vaccine.
34111775 2021. Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine.
34170306 2021. Comparison of COVID-19 Vaccine Approvals at the US Food and Drug Administration, European Medicines Agency, and Health Canada.
34146600 2021. Histologic correlates of gross hematuria following Moderna COVID-19 vaccine in patients with IgA nephropathy.
34119512 2021. Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine.
34119511 2021. Anti-GBM nephritis with mesangial IgA deposits after SARS-CoV-2 mRNA vaccination.
34116086 2021. Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine.
34124415 2021. Humoral Response to SARS-CoV-2 in Hemodialysis Patients.
34179593 2021. Letter regarding: "A Case of Gross Hematuria and IgA Nephropathy Flare-Up Following SARS-CoV-2 Vaccination".
34130372 2021. COVID-19 vaccine-induced acute generalized exanthematous pustulosis.
34126043 2021. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban.
34181881 2021. Heterologous vaccine regimens against COVID-19.
34181880 2021. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
34119034 2021. SARS-CoV-2 vaccination for patients with inflammatory bowel disease.
34119033 2021. SARS-CoV-2 vaccination for patients with inflammatory bowel disease - Authors' reply.
34115963 2021. Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccination.
34173610 2020. COVID-19 Vaccines A Global Common Good.
34153265 2021. SARS-CoV-2 vaccination in people with HIV.
34153264 2021. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.
34111410 2021. Bell's palsy and SARS-CoV-2 vaccines-an unfolding story - Authors' reply.
34111409 2021. Bell's palsy and SARS-CoV-2 vaccines-an unfolding story.
34174193 2021. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.
34174192 2021. Single-dose SARS-CoV-2 vaccination efficacy in the elderly.
34174190 2021. Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.
34147141 2021. COVID-19 vaccination in patients with alpha1-antitrypsin deficiency.
34179831 2021. Adverse events after first COVID-19 vaccination in patients with autoimmune diseases.
34140165 2021. Enfermedades autoinmunes y vacunas contra la COVID-19. Toma de decisiones en escenarios de incertidumbre.
34119341 2021. Eficacia y seguridad de la vacuna frente a SARS-CoV-2 en pacientes con arteritis de celulas gigantes.
34119340 2021. Penfigoide ampolloso y vacuna COVID-19.
34119339 2021. Vacunas COVID-19 e infeccion por herpes.
34133864 2021. mRNA Covid-19 Vaccines in Pregnant Women.
34143345 2021. Headache after COVID-19 vaccination: updated report from the Italian Medicines Agency database.
34128150 2021. Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab.
34138444 2021. Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19.
34117994 2021. Emerging Infection, Vaccination, and Guillain-Barre Syndrome: A Review.
34155481 2021. Emerging issues related to COVID-19 vaccination in patients with cancer.
34137014 2021. Emerging issues related to COVID-19 vaccination in patients with cancer.
34162739 2021. Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.
34184708 2021. Consolidado de recomendaciones del Comite Asesor de Vacunas y Estrategias de Inmunizacion-CAVEI, sobre priorizacion de vacunacion COVID-19.
34149145 2021. Pericarditis tras la administracion de la vacuna de ARNm BNT162b2 contra la COVID-19.
34120531 2021. COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A review of the potential mechanisms and proposed management.
34120357 2021. Exact sequential test for clinical trials and post-market drug and vaccine safety surveillance with Poisson and binary data.
34158837 2021. Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.
34076943 2021. Clinical consequences of the suboptimal effect of messenger RNA-based SARS-CoV-2 vaccine in renal transplant recipients.
34119319 2021. Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects.
34119317 2021. COVID-19 vaccines: A perspective from social pharmacology.
34132881 2021. Beeinflusst Methotrexat die Wirksamkeit der Impfung gegen SARS-CoV-2?
34114269 2021. Guillain-Barre Syndrome Variant Occurring after SARS-CoV-2 Vaccination.
34114256 2021. Guillain-Barre Syndrome following ChAdOx1-S/nCoV-19 Vaccine.
34167947 2021. Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response.
34158370 2021. Systemic rheumatic disease flares after SARS-CoV-2 vaccination among rheumatology outpatients in New York City.
34172502 2021. Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.
34114220 2021. Correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine.
34171971 2021. Maternal and Child Symptoms Following COVID-19 Vaccination Among Breastfeeding Mothers.
34145995 2021. Chimeric Virus-like Particles of Universal Antigen Epitopes of Coronavirus and Phage Qbeta Coat Protein Trigger the Production of Neutralizing Antibodies.
34180347 2021. COVID-19 vaccines: concerns beyond protective efficacy and safety.
34176415 2021. COVID-19 vaccines and thrombosis with thrombocytopenia syndrome.
34105432 2021. Forty days of regulatory emergency use authorisation of COVID-19 vaccines: Interfacing efficacy, hesitancy and SDG target 3.8.
34162139 2021. Regulatory T cells and vaccine effectiveness in older adults. Challenges and prospects.
34120553 2021. Tinnitus following COVID-19 vaccination: report of three cases.
34127187 2021. COVID-19: Bergamo effect and vaccination strategy.
34127186 2021. COVID-19: Effect-modelling of vaccination in Germany with regard to the mutant strain B.1.1.7 and occupancy of ICU facilities.
34110010 2021. Pityriasis rosea after mRNA COVID-19 vaccination.
34118064 2021. A forecast of maternal deaths with and without vaccination of pregnant women against COVID-19 in Mexico.
34115887 2021. Maternal and neonatal SARS-CoV-2 antibodies assessment after mRNA maternal vaccination in the third trimester of pregnancy.
34105336 2021. Anaphylaxis is a rare reaction in COVID-19 vaccination.
34145459 2021. Large-Scale Identification of T-Cell Epitopes Derived From Severe Acute Respiratory Syndrome Coronavirus 2 for the Development of Peptide Vaccines Against Coronavirus Disease 2019.
34175640 2021. Acute Ischemic Stroke Revealing ChAdOx1 nCov-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia: Impact on Recanalization Strategy.
34137808 2021. Sperm Parameters Before and After COVID-19 mRNA Vaccination.
34160567 2021. The Search for a Single Vaccine Against Coronaviruses Yet to Come.
34106201 2021. Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar.
34185047 2021. Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines.
34185046 2021. Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination.
34185045 2021. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.
34100306 2021. Late-onset cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine in an immunocompromised patient.
34161714 2021. Audio Interview: A New mRNA Vaccine.
34133867 2021. Spike D614G - A Candidate Vaccine Antigen Against Covid-19.
34110115 2021. SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
34107187 2021. Audio Interview: Treating Complications of Covid Vaccination.
34133853 2021. Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. Reply.
34133852 2021. Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
34133851 2021. Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
34107179 2021. Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. Reply.
34107178 2021. Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
34182569 2021. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.
34142152 2021. COVID-19 vaccination and dialysis patients: why the variable response.
34117884 2021. Correspondence: Breakthrough COVID-19 Infections among Health Care Workers after Two Doses of ChAdOx1 nCoV-19 Vaccine.
34161019 2021. "Vaccins contre la Covid-19 disponibles en Europe".
34160997 2021. "A propos de l'article Vaccins contre la Covid-19 disponibles en Europe la Covid-19 disponibles en Europe".
34160995 2021. Covid-19 : la course d'obstacles vaccinale.

34100150 2021. Tozinameran (BNT162b2) Vaccine: The Journey from Preclinical Research to Clinical Trials and Authorization.
34133825 2021. Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: A case report.
34171116 2021. Por una priorizacion de las personas con trastornos adictivos en la vacunacion frente a la COVID-19.
34176237 2021. Key Considerations for the Development of Safe and Effective SARS-CoV-2 Subunit Vaccine: A Peptide-Based Vaccine Alternative.
34094633 2021. All Nations Must Prioritize the COVID-19 Vaccination Program for Elderly Adults Urgently.
34128562 2021. COVID-19 vaccine anaphylaxis: PEG or not?
34128561 2021. COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: "COVID-19 vaccine anaphylaxis: PEG or not?"
34128559 2021. Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines.
34185824 2021. Perspectives on COVID-19 vaccination among kidney and pancreas transplant recipients living in New York City.
34175364 2021. Asymptomatic SARS-CoV-2 infection following first dose mRNA-1273 COVID-19 vaccine in a veterans affairs long term care facility.
34182049 2021. De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?
34174364 2021. Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients.
34118200 2021. Adverse effects of COVID-19 messenger RNA vaccines among pregnant women: a cross-sectional study on healthcare workers with detailed self-reported symptoms.
34151047 2021. Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine.
34156871 2021. The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Kappa18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells.
34109031 2021. SARS-CoV-2 Brazil variants in Latin America: More serious research urgently needed on public health and vaccine protection.
34099378 2021. Coronavirus disease vaccination in heart failure: No time to waste.
34155020 2021. Trigeminal and cervical radiculitis after tozinameran vaccination against COVID-19.
34135077 2021. ChAdOx1 nCOV-19 vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis (CVST).
34149203 2021. Fractal-fractional order mathematical vaccine model of COVID-19 under non-singular kernel.
34115904 2021. Asymmetrical cutaneous vasculitis following COVID-19 vaccination with unusual eosinophil preponderance.
34148333 2021. Updates on the coronavirus disease 2019 vaccine and consideration in children.
34111582 2021. Negative SARS-CoV-2 antibodies, T-cell response and virus neutralization following full vaccination in a renal transplant recipient: a call for vigilance.
34111577 2021. Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status.
34174397 2021. B- and T-cell immune responses elicited by the Comirnaty(R) COVID-19 vaccine in nursing-home residents.
34129908 2021. Reconstituted mRNA COVID-19 vaccines may maintain stability after continuous movement.
34153456 2021. COVID-19 vaccination in solid-organ transplant recipients: generating new data as fast as possible, but taking clinical decisions as slow as necessary.
34115709 2021. COVID-19 Vaccination-Associated Lymphadenopathy on FDG PET/CT: Distinctive Features in Adenovirus-Vectored Vaccine.
34178877 2021. Ultrasound and shear-wave elastography patterns of COVID-19 mRNA vaccine-related axillary, supra and subclavicular lymphadenopathy.
34154428 2021. Challenges and opportunities for conducting a vaccine trial during the COVID-19 pandemic in the United Kingdom.
34155052 2021. Feds sign off on mixing and matching COVID-19 vaccines, but evidence gaps remain.
34171857 2021. Coronavirus disease 2019: update on coronavirus disease 2019 outcomes and vaccine efficacy in patients with immune-mediated inflammatory disease.
34166950 2021. COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center.
34124587 2020. COVID-19 vaccine delivery: an opportunity to set up systems for the future.
34127050 2021. Landscape and selection of vaccine epitopes in SARS-CoV-2.
34181021 2021. SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.
34086060 2021. Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report.
34179862 2021. A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.
34121813 2021. Challenges to COVID-19 vaccine supply chain: Implications for sustainable development goals.
34153381 2021. Radiation Recall Phenomenon Following COVID-19 Vaccination.
34155853 2021. Immune Thrombocytopenic Purpura (ITP) Triggered by COVID-19 Infection and Vaccination.
34155844 2021. Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.
34166844 2021. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.
34182162 2021. Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19.
34153517 2021. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.
34112481 2021. Reply to "How important is the second dose of the COVID-19 mRNA vaccine?"
34112480 2021. How important is the second dose of the COVID-19 mRNA vaccine?
34162525 2021. "COVID Toes" After mRNA COVID-19 Vaccines.
34126274 2021. Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination.
34112378 2021. July 2021: Lisinopril for delayed inflammatory responses to hyaluronic acid fillers after COVID-19 vaccinations.
34148772 2021. Type 1 Kounis Syndrome Induced by Inactivated SARS-COV-2 Vaccine.
34131969 2021. Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that 'COVID toes' are due to the immune reaction to SARS-CoV-2.
34131967 2021. Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine.
34112587 2021. Effectiveness of non-pharmaceutical interventions and vaccine for containing the spread of COVID-19: Three illustrations before and after vaccination periods.
34108119 2021. Economic evaluation for mass vaccination against COVID-19.
34175246 2021. Serological response to COVID-19 vaccination in patients with cancer older than 80 years.
34055326 2021. The largest vaccination campaign in history: A golden opportunity for bundling public health interventions.
34132638 2021. Immediate-Type Hypersensitivity to Polyethylene Glycol (PEG) Including a PEG-containing COVID-19 Vaccine Revealed by Intradermal Testing.
34121663 2021. Hypersensitivity to COVID-19 Vaccine Confirmed by a Positive Skin Test Result: A Case Report.
34128597 2021. Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in Korea.
34184663 2021. SARS-CoV-2 Transmission Risk to Household and Family Contacts by Vaccinated Healthcare Workers.
34084042 2021. Need of Vibrant Vaccine Pharmacovigilance During Current Global COVID-19 Pandemic: More Than Ever.
34139754 2021. No COVID-19 vaccines on trash! Exploring effective vaccine management in the Philippines.
34129181 2021. Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis.
34128049 2021. High anaphylaxis rates following vaccination with the Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers: a secondary analysis of initial post-approval safety data.
34132795 2021. Incidence of SARS-CoV-2 Infection in Health Care Workers After a Single Dose of mRNA-1273 Vaccine.
34140660 2021. Author Correction: A global database of COVID-19 vaccinations.
34158650 2021. Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021.
34108714 2021. First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland.
34127854 2021. Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals.
34108716 2021. Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom.
34140665 2021. Using cross-species vaccination approaches to counter emerging infectious diseases.
34161961 2021. Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.
34107529 2021. Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans.
34136730 2021. Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva.
34180130 2021. Varicella-Zoster virus reactivation following SARS-CoV-2 immunization in two patients with leukemia.
34173584 2020. Pfizer: The miracle vaccine for COVID-19?
34172292 2021. Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection.
34178176 2021. Mit der COVID-19-Impfung assoziierte rheumatische Beschwerden.
34159292 2021. COVID-19 vaccine failure in a patient on rituximab therapy.
34142203 2021. Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey.
34110465 2021. Safety and efficacy of COVID-19 vaccines in pregnant women with rheumatic diseases: an immunologic perspective.
34109466 2021. Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly.
34107667 2021. Utviklingshemmede og bruk av tvang ved vaksinering mot covid-19.
34107666 2021. Bor sykehjemsbeboere uten samtykkeevne vaksineres mot covid-19?
34182727 2021. Norge ma si ja til rettferdig tilgang til covid-19-vaksiner.
34088601 2021. Therapeutic plasma exchange (TPE) as a plausible rescue therapy in severe vaccine-induced immune thrombotic thrombocytopenia.
34131585 2021. Kidney Transplant Recipient Attitudes Toward a SARS-CoV-2 Vaccine.
34157078 2021. Strong SARS-CoV-2-neutralizing antibody response of previously-infected healthcare workers given one dose of mRNA vaccine.
34117878 2021. The SARS-CoV-2 mRNA vaccine breakthrough infection phenotype includes significant symptoms, live virus shedding, and viral genetic diversity.
34185632 2021. Is 'original antigenic sin' complicating indian vaccination drive against Covid-19?
34170791 2021. Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management.
34170790 2021. Vaccine certificate during domestic traveling: a potential initiative to prevent COVID-19 waves in India.
34142925 2021. Attitudes of health care professionals towards COVID-19 vaccine - a sequence from Turkey.
34114939 2021. A rational strategy to support approved COVID-19 vaccines prioritization.
34135083 2021. Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.
34112706 2021. Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients.
34117129 2021. Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis.
34154501 2021. COVID-19 vaccination in pregnancy and postpartum.
34130586 2021. Coronavirus disease and vaccination during pregnancy and childbirth: a review of the Israeli perspective and experience.
34185044 2021. Temporal Associations Between Immunization With the COVID-19 mRNA Vaccines and Myocarditis: The Vaccine Safety Surveillance System Is Working.
34160555 2021. Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines.
34110378 2021. Association of COVID-19 mRNA Vaccine With Ipsilateral Axillary Lymph Node Reactivity on Imaging.
34165512 2021. Association of COVID-19 Vaccination and Facial Nerve Palsy: A Case-Control Study.
34119059 2021. ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply.
34119058 2021. ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates.
34111888 2021. BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants.
34113025 2020. Daily briefing: Coronavirus vaccine - where we are now.
34109409 2021. Weekly seroconversion rate of the mRNA-1273 SARS-CoV-2 vaccine in hemodialysis patients.
34120767 2021. One size does not fit all: Lessons from Israel's Covid-19 vaccination drive and hesitancy.
34112629 2021. Covid-19 - Le miracle vaccinal doit inclure rigueur et prudence.
34180608 2021. Biomaterials and nanomaterials for sustained release vaccine delivery.

34153512 2021. From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases.
34133982 2021. Synthetic modified messenger RNA for therapeutic applications.
34169702 2021. Vaccines for COVID-19 in patients with atopic dermatitis: three things every dermatologist should know.
34181082 2021. Vaccination against COVID-19 infection: the need of evidence for diabetic and obese pregnant women.
34101024 2021. Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine.
34178577 2021. Immunologically relevant aspects of the new COVID-19 vaccines-an OGAI (Austrian Society for Allergology and Immunology) and AeDA (German Society for Applied Allergology) position paper.
34153162 2021. Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2.
34144967 2021. Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2.
34127481 2021. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study.
34131510 2021. COVID-19 vaccine-related lymph node activation - patterns of uptake on PET-CT.
34110406 2021. Vaccination against COVID-19: a challenge in CLL.
34110398 2021. Efficacy of COVID-19 vaccine in patients with CLL.
34137813 2021. A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2.
34152403 2021. Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients.
34107889 2021. Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.
34158352 2021. Blood clots, COVID-19 vaccines and the contraceptive pill: are we heading for a repeat of the 1995 pill scare?
34170008 2021. Response to correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine.
34132395 2021. Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms.
34159588 2021. Vaccine-induced immune thrombotic thrombocytopenia (VITT) - a novel clinico-pathological entity with heterogeneous clinical presentations.
34176130 2021. Cold agglutinin disease after COVID-19 vaccine.
34123321 2021. Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies.
34113842 2021. Transient akathisia after the SARS-Cov-2 vaccine.
34146727 2021. Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient.
34113494 2021. Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration.
34141500 2021. A Case of Cervical Lymphadenopathy After Vaccination Against COVID-19.
34150386 2021. A Case of Autoimmune Hemolytic Anemia Following COVID-19 Messenger Ribonucleic Acid Vaccination.
34150372 2021. Rhabdomyolysis Secondary to COVID-19 Vaccination.
34165237 2021. Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male.
34185927 2021. Acute hyperglycaemic crisis after vaccination against COVID-19: A case series.
34186376 2021. Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation.
34186348 2021. COVID-19 vaccine induced rhabdomyolysis: Case report with literature review.
34186339 2021. Exacerbation of hyperglycemia in patients with type 2 diabetes after vaccination for COVID19: Report of three cases.
34106430 2021. Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?
34180795 2021. Intolerance Reaction After Vaccination Against SARS-CoV-2.
34109307 2021. Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine.
34099998 2021. Beyond the jab: A need for global coordination of pharmacovigilance for COVID-19 vaccine deployment.
34102098 2021. Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021.
34102097 2021. Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany.
34176436 2021. Live virus neutralization testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2.
34120577 2021. Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination.
34110974 2021. Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution.
34123472 2021. Next Steps for Efficacy Evaluation in Clinical Trials of COVID-19 Vaccines.
34104127 2021. Advanced packaging for distribution and storage of COVID-19 vaccines: a review.
34117979 2021. Immune age and biological age as determinants of vaccine responsiveness among elderly populations: the Human Immunomics Initiative research program.
34158234 2021. Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine.
34164727 2021. Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immuno-oncology?
34089336 2021. Management of mass casualties due to COVID-19: handling the dead.
34055838 2021. Challenges and Issues of Anti-SARS-CoV-2 Vaccines.
34144046 2021. Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease.
34144044 2021. COVID-19 Vaccination Is Safe and Effective in Patients With Inflammatory Bowel Disease: Analysis of a Large Multi-institutional Research Network in the United States.
34179698 2021. Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.
34157386 2021. Countries with similar COVID-19 vaccination rates yet divergent outcomes: are all vaccines created equal?
34118427 2021. SARS-CoV-2 infection in properly vaccinated healthcare workers.
34116145 2021. Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19.
34129831 2021. Antibody Responses After mRNA-Based COVID-19 Vaccination in Residential Older Adults: Implications for Reopening.
34115991 2021. Emerging Evidence on Effectiveness of COVID-19 Vaccines Among Residents of Long-Term Care Facilities.
34170314 2021. SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses.
34129749 2021. Localized cutaneous reaction to an mRNA COVID-19 vaccine.
34169588 2021. Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2.
34169578 2021. The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?
34166540 2021. Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an 'AstraZeneca arm'?
34117873 2021. COVID-19 mRNA Vaccination Generates Greater Immunoglobulin G Levels in Women Compared to Men.
34166671 2021. Recurrence of Acute Myocarditis Temporally Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a Male Adolescent.
34165239 2021. Suggested treatment of serious complications to COVID-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme.
34105247 2021. Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine.
34105244 2021. First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination.
34117641 2021. The first known case of vaccine-induced thrombotic thrombocytopenia in Australia.
34142670 2021. Effectiveness of BNT162b2 vaccine against SARS-CoV-2 among healthcare workers.
34142785 2021. Thrombosis following Covid-19 vaccination: a possible role of alcohol consumption? A suggestion from the Italian Society on Alcohol.
34132379 2021. COVID19 vaccination and IgG and IgA antibody dynamics in healthcare workers.
34161052 2021. SARS-CoV-2 Variants and Vaccines.
34077639 2021. Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study.
34161702 2021. Effect of Vaccination on Household Transmission of SARS-CoV-2 in England.
34107198 2021. Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia.
34161700 2021. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.
34126004 2021. Delayed Large Local Reactions to mRNA Covid-19 Vaccines in Blacks, Indigenous Persons, and People of Color.
34140469 2021. BNT162b2 vaccine uptake and effectiveness in UK healthcare workers - a single centre cohort study.
34117252 2021. SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung.
34131589 2021. Gamma irradiation-mediated inactivation of enveloped viruses with conservation of genome integrity: Potential application for SARS-CoV-2 inactivated vaccine development.
34152454 2021. Flimmernde Skotome nach COVID-Impfung : Eine weitere mogliche Impfnebenwirkung?
34172313 2021. Dosis unica de la vacuna SARS-CoV-2 m-ARN en personas mayores post-COVID-19.
34180617 2021. Vacuna frente al COVID-19.
34179695 2021. Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19.
34132229 2021. Low Immunization Rate in Kidney Transplant Recipients Also After Dose 2 of the BNT162b2 Vaccine: Continue to Keep Your Guard up!
34130883 2021. Interpreting vaccine efficacy trial results for infection and transmission.
34127291 2021. A new group at increased risk of a SARS-CoV-2 infection emerges: The recently vaccinated.
34120764 2021. Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models.
34119350 2021. Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization.
34167836 2021. The need for broadly protective COVID-19 vaccines: Beyond S-only approaches.
34147292 2021. Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects.
34151248 2021. Increas-ing efficiency in vaccine Production: A primer for change.
34069708 2021. ROS Cocktails as an Adjuvant for Personalized Antitumor Vaccination?
34167952 2021. Covid-19: Should we be worried about reports of myocarditis and pericarditis after mRNA vaccines?
34187101 2021. SARS-CoV-2 antibody assay after vaccination: one size does not fit all.
34162025 2021. Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay.
34117084 2021. Vaccines and Disease Relapses in Children with Nephrotic Syndrome.
34183501 2021. 18F-Fluciclovine-Avid Reactive Axillary Lymph Nodes After COVID-19 Vaccination.
34111682 2021. Successful treatment of acute spleno-porto-mesenteric vein thrombosis after ChAdOx1 nCoV-19 vaccine. A case report.
34176363 2021. The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination.
34116590 2021. COVID-19 vaccine: the gender disparity.
34151698 2021. COVID-19 vaccination in patients on rituximab: a survey of lymphoma physicians at NCI designated cancer centers.
34134555 2021. Lupus, vaccinations and COVID-19: What we know now.
34101717 2021. In brief: Pfizer/BioNTech COVID-19 vaccine authorized for adolescents 12-15 years old.
34183852 2021. Building a pandemic-proof vaccine.
34108715 2021. COVID-19 vaccination and immune thrombocytopenia.
34113015 2021. Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals.
34145414 2021. Coronapod: CureVac disappoints in COVID vaccine trial.
34163051 2021. COVID vaccines and breastfeeding: what the data say.
34145413 2021. CureVac COVID vaccine let-down spotlights mRNA design challenges.
34158390 2021. COVID-19 vaccine side effects: The positives about feeling bad.
34131024 2021. SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques.
34131023 2021. Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients.

34341771 2021. An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell Memory.
34159636 2021. Vaccinating children and adolescents against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-The Israeli experience.
34143448 2021. Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine.
34129694 2021. Delayed local reactions after the first administration of the ChAdOx1 nCoV-19 vaccine.
34128563 2021. COVID-19 vaccines and the role of other potential allergenic components different from PEG. A reply to: "Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines".
34101990 2021. Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients.
34125572 2021. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
34125573 2021. Severe Exacerbations of Systemic Capillary Leak Syndrome After COVID-19 Vaccination: A Case Series.
34174097 2021. Estimating vaccine efficacy over time after a randomized study is unblinded.
34174765 2021. Potential immune response to breast implants after immunization with COVID-19 vaccines.
34156582 2021. COVID-19 vaccination and breast cancer surgery timing.
34118375 2021. Myocarditis After SARS-CoV-2 Vaccination: A Vaccine-Induced Reaction?
34160784 2021. Using observational epidemiology to evaluate COVID-19 vaccines: integrating traditional methods with new data sources and tools.
34133941 2021. Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques.
34174992 2021. Antibody and B cell responses to SARS-CoV-2 infection and vaccination.
34133950 2021. A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses.
34133885 2021. Myocarditis Temporally Associated With COVID-19 Vaccination.
34133884 2021. Myocarditis After BNT162b2 and mRNA-1273 Vaccination.
34133883 2021. In-Depth Evaluation of a Case of Presumed Myocarditis After the Second Dose of COVID-19 mRNA Vaccine.
34142570 2021. Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19.
34166884 2021. Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases.
34116295 2021. Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography.
34147649 2021. Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study.
34166499 2021. Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients.
34166484 2021. Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.
34137815 2021. Post-vaccination SARS-CoV-2 infections and incidence of presumptive B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center.
34134145 2021. The risk of symptomatic infection during a second COVID-19 wave, in SARS-CoV-2 seropositive individuals.
34134134 2021. Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination.
34128970 2021. Antibodies to SARS-CoV-2 in All of Us Research Program Participants, January 2-March 18, 2020.
34156552 2021. [(18)F]FDG uptake of axillary lymph nodes after COVID-19 vaccination in oncological PET/CT: frequency, intensity, and potential clinical impact.
34140294 2021. Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2 specific T cells.
34169819 2021. Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.
34158652 2021. Acute macular neuroretinopathy following COVID-19 vaccination.
34077958 2021. Mandating Clinician COVID-19 Vaccination May Hinder Population-Level Uptake.
34184737 2021. Facial paralysis and vaccinations: a vaccine adverse event reporting system review.
34177237 2021. COVID-19 Vaccine in Veterans with Multiple Sclerosis: Protect the Vulnerable.
34148583 2021. Should women undergoing in vitro fertilization treatment or who are in the first trimester of pregnancy be vaccinated immediately against COVID-19.
34149815 2021. Correlation Between SARS-Cov-2 Vaccination, COVID-19 Incidence and Mortality: Tracking the Effect of Vaccination on Population Protection in Real Time.
34179072 2021. A Minireview of the Promising Drugs and Vaccines in Pipeline for the Treatment of COVID-19 and Current Update on Clinical Trials.
34123704 2021. Outbreak of infections with the COVID-19 virus mutation B.1.351 about four weeks after the second successful vaccination with BNT162b2.
34123703 2021. Symptoms, antibody levels and vaccination attitude after asymptomatic to moderate COVID-19 infection in 200 healthcare workers.
34170788 2021. COVID-19 vaccine development from the perspective of cancer patients.
34161189 2021. Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies.
34114940 2021. The pivotal roles of the host immune response in the fine-tuning the infection and the development of the vaccines for SARS-CoV-2.
34114927 2021. Are people previously infected with SARS-CoV-2 likely to experience COVID-19 symptoms again after vaccination? Results from an Italian COVID-19 referral center.
34145775 2021. Skin rashes after SARS-CoV-2 vaccine: which relationship, if any?
34145087 2021. Heterogeneity in protocols for bronchoalveolar lavage & sub-genomic RNA evaluation in non-human primate studies of SARS-CoV-2 vaccine candidates' evaluation.
34146066 2021. Corneal graft rejection after COVID-19 vaccination.
34167610 2021. Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers.
34176397 2021. Transmission of SARS-CoV-2 variant B.1.1.7 among vaccinated health care workers.
34174723 2021. Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data.
34139631 2021. Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines.
34177192 2021. COVID-19 vaccines in patients with chronic liver disease.
34143755 2021. Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipients.
34144891 2021. COVID-19 vaccination immune paresis in heart and lung transplantation.
34120839 2021. Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients.
34116081 2021. Autoimmune hepatitis following SARS-CoV-2 vaccine: May not be a casuality.
34146650 2021. Reply to: "Comment on "Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?"".
34171435 2021. Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine.
34153398 2021. Autoimmune hepatitis following COVID-19 vaccination: True causality or mere association?
34129886 2021. Another case of autoimmune hepatitis after SARS-CoV-2 vaccination - still casualty?
34056008 2021. Induction of Humoral and Cellular Immunity by Intradermal Delivery of SARS-CoV-2 Nucleocapsid Protein Using Dissolvable Microneedles.
34117117 2021. Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients.
34161817 2021. Waning antibodies in SARS-CoV-2 naive vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers.
34147528 2021. One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection.
34106888 2021. Heterologous immunization with Covishield and Pfizer vaccines against SARS-CoV-2 elicits a robust humoral immune response.
34175235 2021. A patient presenting with ARDS after COVID-19 vaccination: A COVID-19 case report.
34119848 2021. Design of a novel multiple epitope-based vaccine: An immunoinformatics approach to combat SARS-CoV-2 strains.
34109263 2021. Localized and generalized urticarial allergic dermatitis secondary to SARS-CoV-2 vaccination in a series of 6 patients.
34174324 2021. Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.
34137703 2021. Las variantes de SARS-CoV-2 y la llamada resistencia a las vacunas.
34137701 2021. Monitoreo activo de la seguridad temprana de la vacunacion con Sputnik V en Buenos Aires, Argentina.
34179744 2021. Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story.
34183681 2021. COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.
34133415 2021. Human IgG and IgA responses to COVID-19 mRNA vaccines.
34149984 2021. Axillary lymphadenopathy in a renal cell carcinoma patient after COVID-19 Vaccination.
34136745 2021. Vaccine-induced Immune Thrombocytopenia and Thrombosis (VITT).
34100388 2021. Use of COVID-19 vaccines in patients with liver disease and post-liver transplantation: Position statement of the Saudi association for the study of liver diseases and transplantation.
34286849 2021. Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy.
34173235 2021. The evolution of COVID-19 vaccination within a US blood center.
34172647 2021. Successful Liver Transplantation From a Deceased Donor With Vaccine-Induced Thrombotic Thrombocytopenia Causing Cerebral Venous Sinus and Hepatic Veins Thrombosis After ChAdOx1 nCov-19 Vaccination.
34155187 2021. Persistent Immunogenicity of the mRNA COVID-19 Vaccine in Patients Vaccinated Before Kidney Transplant.
34149002 2021. Immediate Impact of Induction Treatment on Postvaccination SARS-CoV-2 Serology in Kidney Transplant Recipients.
34238372 2021. Immunoinformatics approach for multi-epitope vaccine design against structural proteins and ORF1a polyprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
34287384 2021. High Effectiveness of SARS-CoV-2 Vaccines in Reducing COVID-19-Related Deaths in over 75-Year-Olds, Ceara State, Brazil.
34090699 2021. Methodologic approaches in studies using real-world data (RWD) to measure pediatric safety and effectiveness of vaccines administered to pregnant women: A scoping review.
34204501 2021. Immune Response to Vaccination against COVID-19 in Breastfeeding Health Workers.
34204252 2021. First Dose of the BNT162b2 mRNA COVID-19 Vaccine Reduces Symptom Duration and Viral Clearance in Healthcare Workers.
34203652 2021. Neutralizing Anti-SARS-CoV-2 Antibody Titer and Reported Adverse Effects, in a Sample of Italian Nursing Home Personnel after Two Doses of the BNT162b2 Vaccine Administered Four Weeks Apart.
34198562 2021. Impacts of Side Effects to BNT162b2 and the First Dose of ChAdOx1 Anti-SARS-CoV-2 Vaccination on Work Productivity, the Need for Medical Attention, and Vaccine Acceptance: A Multicenter Survey on Healthcare Workers in Referral Teaching Hospitals in the Republic of Korea.
34208032 2021. A Murine CD8(+) T Cell Epitope Identified in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein.
34200648 2021. COVID-19 Vaccination in Patients with Classic Kaposi's Sarcoma.
34200587 2021. A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals.
34200538 2021. Interim Estimates of COVID-19 Vaccine Effectiveness in a Mass Vaccination Setting: Data from an Italian Province.
34206032 2021. Efficacy and Safety of COVID-19 Vaccines in Phase III Trials: A Meta-Analysis.
34304693 2021. COVID-19 variants as moving targets and how to stop them by glycoengineered whole-virus vaccines.
34087261 2021. Adenoviral Vector DNA- and SARS-CoV-2 mRNA-Based Covid-19 Vaccines: Possible Integration into the Human Genome - Are Adenoviral Genes Expressed in Vector-based Vaccines?
34277894 2021. A theoretical strategy for acceleration of human immune response against SARS-CoV-2: a fusion protein harboring virus-binding and pre-exposed antigen domains.
34206727 2021. Case Study of Two Post Vaccination SARS-CoV-2 Infections with P1 Variants in CoronaVac Vaccinees in Brazil.
34205940 2021. DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination.
34181394 2021. Lipid Nanoparticles-From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement.
34159781 2021. Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody Responses.
34147137 2021. Trombose, Hemorragia e Trombocitopenia Induzidas pelas Vacinas contra a COVID-19: Protocolo de Atuacao.
34112639 2021. Covid-19: AstraZeneca vaccine linked with small risk of ITP, real world data show.
34180390 2021. Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine.
34112673 2021. Mixing vaccines may boost immune responses.
34112671 2021. 'Landmark' African vaccine trial faces impasse.
34169493 2021. PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison.
34096896 2021. Unique Imaging Findings of Neurologic Phantosmia Following Pfizer-BioNtech COVID-19 Vaccination: A Case Report.
34144554 2021. SARS-CoV-2 Vaccination, Immune Responses, and Antibody Testing in Immunosuppressed Populations: Tip of the Iceberg.
34115658 2021. Transplantation Outcome in Recipients Engrafted With Organs Recovered From the First French Deceased Donor With a SARS-COV-2 Vaccine-induced Thrombotic Thrombocytopenia.
34098566 2021. Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients.

34309055 2021. Personalized health and the coronavirus vaccines-Do individual genetics matter?
34315454 2021. Evaluation of the safety profile of COVID-19 vaccines: a rapid review.
34304742 2021. Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals.
34256745 2021. Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.
34253200 2021. Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts.
34192529 2021. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.
34242578 2021. Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.
34265281 2021. Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.
34265245 2021. The success of SARS-CoV-2 vaccines and challenges ahead.
34265240 2021. Beyond neutralization for BNT162b2 mRNA vaccination.
34282299 2021. Improvement of a SARS-CoV-2 vaccine by enhancing the conjugation efficiency of the immunogen to self-assembled nanoparticles.
34267334 2021. SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients.
34289385 2021. An intranasal vaccine durably protects against SARS-CoV-2 variants in mice.
34245672 2021. A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.
34293114 2021. The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living with HIV.
34282839 2021. Prevention of COVID-19 by mRNA-based vaccines within the general population of California.
34260716 2021. Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection.
34278286 2021. Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals.
34278284 2021. A modelling study investigating short and medium-term challenges for COVID-19 vaccination: From prioritisation to the relaxation of measures.
34250456 2021. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.
34222848 2021. Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC-COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study.
34296676 2021. Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021.
34269175 2021. Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021.
34269172 2021. Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March-June 2021, England.
34240699 2021. An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021.
34212840 2021. Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021.
34212838 2021. Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel.
34322129 2021. SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants.
34276681 2021. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
34262569 2021. Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.
34249017 2021. Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk.
34248993 2021. Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets.
34234787 2021. Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis.
34220867 2021. The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients.
34220854 2021. Chronic Immune Activation and CD4(+) T Cell Lymphopenia in Healthy African Individuals: Perspectives for SARS-CoV-2 Vaccine Efficacy.
34211472 2021. Circulating Extracellular Vesicles Carry Immune Regulatory miRNAs and Regulate Vaccine Efficacy and Local Inflammatory Response After Vaccination.
34325615 2021. Cord blood antibody following maternal SARS-CoV-2 inactive vaccine (CoronaVac) administration during the pregnancy.
34283001 2021. Early approval of COVID-19 vaccines: Pros and cons.
34254894 2021. Landscape and progress of global COVID-19 vaccine development.
34241575 2021. Can children of the Sputnik V vaccine recipients become symptomatic?
34242123 2021. SARS-CoV-2 vaccination in the context of original antigenic sin.
34324409 2021. Comparison of immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccine (CoronaVac) in previously SARS-CoV-2 infected and uninfected health care workers.
34189042 2021. Acute myocarditis following administration of BNT162b2 vaccine.
34314576 2021. SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors.
34270939 2021. COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge.
34303920 2021. Antigenic sites in SARS-CoV-2 spike RBD show molecular similarity with pathogenic antigenic determinants and harbors peptides for vaccine development.
34324159 2021. Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab.
34242841 2021. Is the second dose of vaccination useful in previously SARS-CoV-2-infected healthcare workers?
34225791 2021. Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials.
34264514 2021. Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine.
34325045 2021. Letter to the Editor: Can the seasonal influenza vaccine for 2019/2020 have cross reactivity with some of the SARS-CoV-2 proteins?
34325043 2021. Influenza immunization and COVID-19-can viral structure be responsible for the effect?
34320413 2021. Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 Vaccine in Saudi Arabia.
34289406 2021. Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence?
34216738 2021. Interferon-gamma release assay testing to assess COVID-19 vaccination response in a SARS-CoV-2 seronegative patient on rituximab: a case report.
34271203 2021. Reduction in COVID-19 prevalence in healthcare workers in a university hospital in southern Brazil after the start of vaccination.
34322400 2021. Diagnostic tools for evaluating the effectiveness of COVID 19 vaccines: Challenges and solution.
34294590 2021. Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report.
34247945 2021. Antibodies against Receptor Binding Domain of SARS-CoV-2 spike protein induced by BNT162b2 vaccine: results from a pragmatic, real-life study.
34303125 2021. Active Covid-19 infection and transmission after the first dose of the BNT162b2 mRNA vaccination in Saudi Arabia: A case report.
34293641 2021. SARS-CoV-2 anti-spike antibody titres after vaccination with BNT162b2 in naive and previously infected individuals.
34314037 2021. The dynamics of quantitative SARS-CoV-2 antispike IgG response to BNT162b2 vaccination.
34270094 2021. Safety of COVID-19 vaccines.
34264528 2021. Safety and effectiveness of SARS-CoV-2 vaccines: A systematic review and meta-analysis.
34251683 2021. Relapse of microscopic polyangiitis after vaccination against COVID-19: A case report.
34197764 2021. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial.
34324836 2021. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial.
34308395 2021. Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19.
34223399 2021. Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK.
34258603 2021. Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.
34318288 2021. Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.
34250518 2021. Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel.
34205564 2021. Confounding Factors Influencing the Kinetics and Magnitude of Serological Response Following Administration of BNT162b2.
34208751 2021. Coordinate Induction of Humoral and Spike Specific T-Cell Response in a Cohort of Italian Health Care Workers Receiving BNT162b2 mRNA Vaccine.
34279108 2021. RBD-Modified Bacterial Vesicles Elicited Potential Protective Immunity against SARS-CoV-2.
34193869 2021. CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.
34326317 2021. Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers.
34258322 2021. Impact of Previous Coronavirus Disease 2019 on Immune Response After a Single Dose of BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
34206507 2021. A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development.
34280210 2021. Modeling vaccination strategies in an Excel spreadsheet: Increas-ing the rate of vaccination is more effective than increas-ing the vaccination coverage for containing COVID-19.
34290317 2021. Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice.
34312010 2021. The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying Mechanism.
34304928 2021. An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity.
34303561 2021. Vitamin D supplementation: An alternative to enhance the effectiveness of vaccines against SARS-CoV-2?
34274126 2021. Significance of SARS-CoV-2 specific antibody testing during COVID-19 vaccine allocation.
34207916 2021. Vaccination in PADs.
34201330 2021. A Quantitative Benefit-Risk Analysis of ChAdOx1 nCoV-19 Vaccine among People under 60 in Italy.
34201065 2021. Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination.
34208884 2021. Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines.
34206865 2021. Multi-Subunit SARS-CoV-2 Vaccine Design Using Evolutionarily Conserved T- and B- Cell Epitopes.
34202276 2021. Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination.
34206312 2021. Early Onset of SARS-COV-2 Antibodies after First Dose of BNT162b2: Correlation with Age, Gender and BMI.
34199384 2021. Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans.
34199357 2021. Titers, Prevalence, and Duration of SARS-CoV-2 Antibodies in a Local COVID-19 Outbreak and Following Vaccination.
34207394 2021. Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia.
34207369 2021. Safety of ChAdOx1 nCoV-19 Vaccine: Independent Evidence from Two EU States.
34207300 2021. BNT162b2 mRNA SARS-CoV-2 Vaccine Elicits High Avidity and Neutralizing Antibodies in Healthcare Workers.
34205917 2021. Side Effects Reported by Jordanian Healthcare Workers Who Received COVID-19 Vaccines.
34205898 2021. Pancreatic Injury after COVID-19 Vaccine-A Case Report.
34205888 2021. The Beauty of Simplicity: Delayed-Type Hypersensitivity Reaction to Measure Cellular Immune Responses in RNA-SARS-Cov-2 Vaccinated Individuals.
34205861 2021. Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2.
34207378 2021. Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants.
34417167 2021. Covid-19 booster vaccines: What we know and who's doing what.
34400478 2021. Intradermal covid-19 vaccination could solve supply problems.
34400411 2021. Covid-19: Two vaccine doses are crucial for protection against delta, study finds.
34251248 2021. Interrupting vaccination policies can greatly spread SARS-CoV-2 and enhance mortality from COVID-19 disease: The AstraZeneca case for France and Italy.
34236343 2021. Thrombosis with thrombocytopenia syndrome after COVID-19 vaccination.
34216472 2021. An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.
34312162 2021. Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients.
34281983 2021. COVID-19 Vaccination Imperatives in People on Maintenance Dialysis: An International Perspective.
34269723 2021. DOTATATE Uptake in an Axillary Lymph Node After COVID-19 Vaccination.
34269722 2021. Features of Systemic Immune Response From COVID-19 Vaccination on 18F-FDG PET/CT.

34245636 2021. Reaching the hard to reach: Characteristics of patients who received a COVID-19 vaccine in the emergency department.
34310793 2021. Myopericarditis in young adults presenting to the emergency department after receiving a second COVID-19 mRNA vaccine.
34286517 2021. Cancer patients and internal medicine patients attitude towards COVID-19 vaccination in Poland.
34324884 2021. Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across.
34280513 2021. Prophylactic vaccine delivery systems against epidemic infectious diseases.
34277326 2021. Answers to burning questions for clinical allergologists related to the new COVID-19 vaccines.
34370884 2021. Safe administration of the Pfizer-BioNtTech COVID-19 vaccine following an immediate reaction to the first dose.
34386995 2021. A single dose of BNT162b2 vaccine elicits strong humoral response in SARS-CoV-2 seropositive individuals.
34280507 2021. ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine.
34273435 2021. COVID-19 Vaccination in Immunoglobulin A Nephropathy.
34242687 2021. Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report.
34331842 2021. Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients.
34331745 2021. COVID-19 after two doses of mRNA vaccines in kidney transplant recipients.
34370901 2021. Boosters and optimizing SARS-CoV-2 vaccine for transplantation: No time to wait.
34347934 2021. Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients.
34226070 2021. Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination.
34309715 2021. Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine.
34302519 2021. Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis.
34274547 2021. Covid vaccination in patients with autoimmune diseases treated with mycophenolate: Let's think back to the recommendations.
34325334 2021. Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination.
34312487 2021. ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models.
34188432 2021. Modeling the impact of SARS-CoV-2 variants and vaccines on the spread of COVID-19.
34308402 2021. Case report of lymph node activation mimicking cancer progression: A false positive F(18) FDG PET CT after COVID-19 vaccination.
34202032 2021. Direct Measurement of B Lymphocyte Gene Expression Biomarkers in Peripheral Blood Transcriptomics Enables Early Prediction of Vaccine Seroconversion.
34192217 2020. SARS-CoV-2 Vaccine.
34320792 2021. It is time to adapt anti-CD20 administration schedule to allow efficient anti-SARS-Cov-2 vaccination in patients with lymphoid malignancies.
34320790 2021. Humoral serologic response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies.
34320789 2021. Safety and efficacy of BNT162b mRNA Covid19 Vaccine in patients with chronic lymphocytic leukemia.
34195051 2021. A generalized pustular psoriasis flare after CoronaVac COVID-19 vaccination: Case report.
34288354 2021. Successful COVID-19 vaccination for patients on dialysis in Vilnius County.
34299876 2021. The Ecological Footprint of COVID-19 mRNA Vaccines: Estimating Greenhouse Gas Emissions in Germany.
34224924 2021. Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders.
34293500 2021. Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19.
34293499 2021. An academic hospital experience screening mRNA COVID-19 vaccine risk using patient allergy history.
34246432 2021. Ascertainment Bias in Anaphylaxis Safety Data of COVID-19 Vaccines.
34293683 2021. Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?
34237190 2021. Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming.
34237179 2021. Immunogenicity of SARS-CoV-2 mRNA vaccine in solid organ transplant recipients.
34309514 2021. Polyethylene glycol allergy and immediate-type hypersensivitity reaction to COVID-19 vaccination: case report.
34222851 2021. Major cardiac concerns in therapy and vaccinations for COVID-19.
34260903 2021. Partial protection of Sinopharm vaccine against SARS COV2 during recent outbreak in Bahrain.
34312390 2021. Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants.
34312554 2021. Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination.
34262158 2021. Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.
34290390 2021. Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom.
34211186 2021. Immunological mechanisms of vaccine-induced protection against COVID-19 in humans.
34320609 2021. Rapid and stable mobilization of CD8(+) T cells by SARS-CoV-2 mRNA vaccine.
34326180 2021. COVID-19 and Vaccination in the Setting of Neurologic Disease: An Emerging Issue in Neurology.
34294728 2021. A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19.
34248208 2021. Is it possible to ensure COVID19 vaccine supply by using plants?
34267103 2021. Otologic Manifestations After COVID-19 Vaccination: The House Ear Clinic Experience.
34203729 2021. A Comprehensive Overview on the Production of Vaccines in Plant-Based Expression Systems and the Scope of Plant Biotechnology to Combat against SARS-CoV-2 Virus Pandemics.
34234013 2021. Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.
34293165 2021. Herpes zoster following COVID-19 vaccine: a report of three cases.
34247246 2021. COVID-19 vaccine-associated acute cerebral venous thrombosis and pulmonary artery embolism.
34297134 2021. Letter re 'Breakthrough COVID-19 infections among health care workers after two doses of ChAdOx1 nCoV-19 vaccine'.
34297133 2021. The reversible tinnitus and cochleopathy followed first-dose AstraZeneca COVID-19 vaccination.
34297117 2021. Response to letter re Breakthrough COVID-19 infections among health care workers after two doses of ChAdOx1 nCoV-19 vaccine.
34297113 2021. COVID-19 vaccination effect on tracer uptake with FDG-PET/CT.
34192262 2020. Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity.
34318475 2021. Vaccine for Covid-19 and Pregnant Women.
34306300 2021. Anaphylaxis and COVID-19 vaccines: Real-time interest using Google Trends.
34219448 2021. SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies.
34375049 2021. COVID-19 Vaccine-Associated Takotsubo Cardiomyopathy.
34453872 2021. Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients.
34431207 2021. Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept.
34326067 2021. Covid-19: NICE issues guidance on vaccine induced immune thrombocytopenia and thrombosis.
34301631 2021. Covid-19: Longer interval between Pfizer doses results in higher antibody levels, research finds.
34261628 2021. Covid-19: Regulators warn that rare Guillain-Barre cases may link to J&J and AstraZeneca vaccines.
34193597 2021. Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.
34227230 2021. Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis and heparin induced thrombocytopenia: Results from a UK National External Quality Assessment Scheme exercise April 2021.
34287612 2021. Bilateral Acute Macular Neuroretinopathy After Vaccination Against SARS-CoV-2.
34329200 2021. Septic Arthritis of the Shoulder After SARS-CoV-2 Pfizer Vaccination: A Case Report.
34308748 2021. Low rate of seroconversion after mRNA anti-SARS-CoV-2 vaccination in patients with hematological malignancies.
34313175 2021. Between a rock and a hard place: COVID-19 vaccination and patients on rituximab therapy.
34192958 2021. SARS-CoV-2 vaccination efficacy and B-cell depletion therapy in systemic lupus erythematosus: Description of a case.
34233102 2021. Audio Interview: How Well Are Covid-19 Vaccines Working?
34260844 2021. Audio Interview: Monoclonal Antibodies and Vaccine Boosts.
34192438 2021. Audio Interview: Another New Covid-19 Vaccine.
34192432 2021. Cerebral Venous Thrombosis.
34312555 2021. A 'mix and match' approach to SARS-CoV-2 vaccination.
34244681 2021. mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar.
34267382 2021. Another COVID-19 vaccine to boost rollout.
34239135 2021. A correlate of protection for SARS-CoV-2 vaccines is urgently needed.
34253930 2021. A French cohort for assessing COVID-19 vaccine responses in specific populations.
34226735 2021. Fractionation of COVID-19 vaccine doses could extend limited supplies and reduce mortality.
34244690 2021. Quarter-dose of Moderna COVID vaccine still rouses a big immune response.
34326510 2021. A blood marker predicts who gets 'breakthrough' COVID.
34215859 2021. Coronapod: the biomarker that could change COVID vaccines.
34272530 2021. Coronapod: does England's COVID strategy risk breeding deadly variants?
34211170 2021. Scientists identify long-sought marker for COVID vaccine success.
34230663 2021. Mounting evidence suggests Sputnik COVID vaccine is safe and effective.
34321643 2021. COVID vaccines slash viral spread - but Delta is an unknown.
34252919 2021. Systems vaccinology of the BNT162b2 mRNA vaccine in humans.
34233346 2021. Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia.
34294926 2020. Daily briefing: The biotech building a better, faster, stronger coronavirus vaccine.
34285395 2020. Daily briefing: Three vaccines show early promise for COVID-19.
34228411 2021. Wat zijn de verschillen tussen diverse vaccins tegen COVID-19?
34312301 2021. Adenovirus-Vectored COVID-19 Vaccine-Induced Immune Thrombosis of Carotid Artery: A Case Report.
34275860 2021. Immunoinformatics approaches to explore B and T cell epitope-based vaccine designing for SARS-CoV-2 Virus.
34230101 2021. Reply to Dushoff et al. and Pifarre i Arolas et al.: Age prioritization for COVID-19 vaccination does save lives and years of life.
34230099 2021. Transmission dynamics are crucial to COVID-19 vaccination policy.
34328282 2021. The level of protective post-vaccination antibodies in NIPH-NIH employees after administration of Pfizer vaccine against COVID-19.
34264042 2021. Epidemiologie de COVID-19 et vaccination : etude de modelisation.
34215591 2021. Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.
34266981 2021. A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.
34210786 2021. Implications of defective immune responses in SARS-CoV-2 vaccinated organ transplant recipients.
34315826 2021. Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models.
34315825 2021. Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates.
34285130 2021. A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters.
34244387 2021. Can immune responses predict which vaccines work best?
34326217 2021. The overlooked superpower of mRNA vaccines.

34455440 2021. COVID-19 vaccine use in immunocompromised patients: A commentary on evidence and recommendations.
34390501 2021. Serologic response to mRNA COVID-19 vaccination in lymphoma patients.
34331712 2021. Impaired response to first SARS-CoV-2 dose vaccination in myeloproliferative neoplasm patients receiving ruxolitinib.
34363871 2021. Introduction of the BNT162b2 vaccine during a COVID-19 nursing home outbreak.
34352358 2021. Detection of neutralizing anti-severe acute respiratory syndrome coronavirus 2 antibodies in patients with common variable immunodeficiency after immunization with messenger RNA vaccines.
34343675 2021. Specific antibody response of patients with common variable immunodeficiency to BNT162b2 coronavirus disease 2019 vaccination.
34343674 2021. Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result.
34333959 2021. Ipsilateral Axillary Adenopathy from mRNA COVID-19 Vaccines.
34305491 2021. Forecasting fully vaccinated people against COVID-19 and examining future vaccination rate for herd immunity in the US, Asia, Europe, Africa, South America, and the World.
34366169 2021. COVID-19 Vaccine Guidance for Patients with Cancer in Mexico: Report From the Working Group of the Mexican Society of Oncology.
34312136 2021. Acute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine.
34281950 2021. Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses.
34261635 2021. Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine.
34261633 2021. Coeliac artery and splenic artery thrombosis complicated with splenic infarction 7 days following the first dose of Oxford vaccination, causal relationship or coincidence?
34257129 2021. Thrombosis and thrombocytopaenia after ChAdOx1 nCoV-19 vaccination: a single UK centre experience.
34192020 2021. Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.
34215611 2021. India's pragmatic vaccination strategy against COVID-19: a mathematical modelling-based analysis.
34220353 2021. Demonstrating the capacity of the National Advisory Committee on Immunization for timely responses to post-market vaccine monitoring signals: Canada's experience with the live-attenuated influenza vaccine.
34428917 2021. Myocarditis Associated With COVID-19 Vaccination: Echocardiography, Cardiac Tomography, and Magnetic Resonance Imaging Findings.
34283338 2021. Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine.
34324086 2021. The effect of a single dose of BNT162b2 vaccine on the incidence of severe COVID-19 infection in patients on chronic hemodialysis: a single-centre study.
34230841 2021. Emerging infectious diseases, vaccines and Guillain-Barre syndrome.
34222129 2021. Inside the story about the research and development of COVID-19 vaccines.
34222128 2021. Fight against COVID-19 with mRNA vaccines and interaction with Dermal fillers.
34325221 2021. COVID-19 vaccine-related unilateral axillary lymphadenopathy: Pattern on screening breast MRI allowing for a benign assessment.
34303188 2021. Axillary adenopathy following COVID-19 vaccination: A single institution case series.
34298342 2021. Unilateral axillary adenopathy in the setting of COVID-19 vaccine: Follow-up.
34214649 2021. Detection of immunoglobulin response to COVID-19 vaccination using a novel rapid fingerstick assay.
34244723 2021. Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including Alpha and Gamma variants: a test-negative design in adults 70 years and older in British Columbia, Canada.
34192576 2021. Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines.
34265462 2021. Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data.
34245907 2021. BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel.
34197936 2021. SARS-CoV-2 new infections among health-care workers after the first dose of the BNT162b2 mRNA COVID-19 vaccine. A hospital-wide cohort study.
34329793 2021. Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study.
34277256 2021. New-Onset Neurologic Symptoms and Related Neuro-Oncologic Lesions Discovered After COVID-19 Vaccination: Two Neurosurgical Cases and Review of Post-Vaccine Inflammatory Responses.
34277203 2021. A Case of COVID-19 Vaccine Causing a Myasthenia Gravis Crisis.
34277198 2021. Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines.
34268022 2021. COVID-19 Vaccination-Induced Rash: Does the Choice of Vaccine Matter?
34235030 2021. Subacute Thyroiditis After Receiving the Adenovirus-Vectored Vaccine for Coronavirus Disease (COVID-19).
34293552 2021. COVID-19 vaccine-induced myocarditis: Case report with literature review.
34284226 2021. Elucidating causes of COVID-19 infection and related deaths after vaccination.
34280733 2021. Potential adverse effects of COVID19 vaccines among Iraqi population; a comparison between the three available vaccines in Iraq; a retrospective cross-sectional study.
34206567 2021. Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine.
34288285 2021. Safety of the BNT162b2 COVID-19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel.
34189948 2021. Indications for and contraindications of immune checkpoint inhibitors in cancer patients with COVID-19 vaccination.
34258873 2021. A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS-CoV-2 vaccine.
34251972 2021. Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia.
34275656 2021. Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination.
34271109 2021. Placebo-controlled trials with COVID-19 vaccines: participants first.
34271108 2021. Ethics of COVID-19 vaccine trials in rapidly changing contexts.
34305352 2021. Exercise caution with ChAdOx1 COVID-19 vaccination in Chronic Budd-Chiari syndrome with a thrombophilic genetic predisposition.
34291391 2021. Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies.
34202817 2021. Neurosurgical Considerations Regarding Decompressive Craniectomy for Intracerebral Hemorrhage after SARS-CoV-2-Vaccination in Vaccine Induced Thrombotic Thrombocytopenia-VITT.
34203769 2021. Prevalence and Risk Factors of CoronaVac Side Effects: An Independent Cross-Sectional Study among Healthcare Workers in Turkey.
34323111 2021. Analysis of Continuous Blood Glucose Data in People with Type 1 Diabetes (T1DM) After COVID-19 Vaccination Indicates a Possible Link Between the Immune and the Metabolic Response.
34281760 2021. Acute corneal endothelial graft rejection following COVID-19 vaccination.
34291376 2021. Delayed Hypersensitivity Reactions Following First Dose of the SARS-CoV2 mRNA Vaccines.
34232526 2021. SARS-CoV-2 vaccine-induced prothrombotic immune thrombocytopenia: Promoting awareness to improve patient-doctor trust.
34214206 2021. AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report.
34284342 2021. Hyperacute reversible encephalopathy related to cytokine storm following COVID-19 vaccine.
34274719 2021. Commentary: The spectrum of neurological manifestations related to COVID-19 and vaccinations.
34224024 2021. Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination.
34228985 2021. Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents.
34219532 2021. Acute Myocardial Injury Following COVID-19 Vaccination: A Case Report and Review of Current Evidence from Vaccine Adverse Events Reporting System Database.
34210829 2021. A Case of Chilblains-like Lesions Post SARS-CoV-2 Vaccine?
34314875 2021. Secondary thrombocytopenia after SARS-CoV-2 vaccine: Report of a case of hemorrhage and hematoma after minor oral surgery.
34312992 2021. Laboratory testing for post ChAdOx1 nCOV-19 vaccination VITT: A challenge. Comment on: Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology.
34224753 2021. Serological response to a single dose of a SARS-CoV-2 mRNA vaccine.
34246586 2021. Possible Association Between COVID-19 Vaccine and Myocarditis: Clinical and CMR Findings.
34246585 2021. A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2.
34236995 2021. Physiologic Response to the Pfizer-BioNTech COVID-19 Vaccine Measured Using Wearable Devices: Prospective Observational Study.
34218852 2021. Vaccination Safety: Don't Toss the Champagne With the Cork.
34222853 2021. A colloidal gold-based immunochromatographic strip for rapid detection of SARS-CoV-2 antibodies after vaccination.
34235592 2021. Vaccination of cancer patients against COVID-19: towards the end of a dilemma.
34198208 2021. Maternal vaccines during the Covid-19 pandemic:A qualitative interview study with UK pregnant women.
34189662 2021. Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19.
34324120 2021. Functional neurological disorder after COVID-19 vaccination.
34322761 2021. Bell's palsy following COVID-19 vaccination with high CSF antibody response.
34272622 2021. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine.
34260633 2021. The impact of vaccination to control COVID-19 burden in the United States: A simulation modeling approach.
34245485 2021. Delirium in a patient with Alzheimer's dementia following COVID-19 vaccination.
34306275 2021. Quadrilateral space region inflammation and other incidental findings on shoulder MRI following recent COVID-19 vaccination: Three case reports.
34327553 2021. Hirnvenen- und Sinusthrombose nach COVID-19-Schutzimpfung : Neurologisch-radiologisches Prozedere.
34244818 2021. Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt.
34325717 2021. Modelling the impact of delaying vaccination against SARS-CoV-2 assuming unlimited vaccine supply.
34324256 2021. Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients.
34288294 2021. Transplantation programs facing lack of empirical evidence on SARS-CoV-2 vaccination: A society recommendation consensus update.
34214738 2021. Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.
34293520 2021. Serologic Responses following a Single Dose of SARS-Cov-2 Vaccination in Allogeneic Stem Cell Transplantation Recipients.
34274492 2021. Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant Recipients.
34319928 2021. Breakthrough COVID-19 Infections After mRNA Vaccination in Solid Organ Transplant Recipients in Miami, Florida.
34241987 2021. Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients.
34310531 2021. Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients.
34310530 2021. Two Doses of SARS-CoV-2 Vaccines Reduce Risk of Death Due to COVID-19 in Solid Organ Transplant Recipients: Preliminary Outcomes From a UK Registry Linkage Analysis.
34310101 2021. Humoral Response of Renal Transplant Recipients to the BNT162b2 SARS-CoV-2 mRNA Vaccine Using Both RBD IgG and Neutralizing Antibodies.
34284420 2021. SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19.
34198360 2021. Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine.
34235275 2021. Vaccine-enhanced disease: case studies and ethical implications for research and public health.
34370541 2021. Support Pharmacy Infrastructure to Strengthen US COVID-19 Vaccination Efforts and Beyond.
34370533 2021. Vaccination of the Elderly in Assisted Living by the Israeli Emergency Medical Services.
34355820 2021. Successful vertical transmission of SARS-CoV-2 antibodies after maternal vaccination.
34330713 2021. Covid-19: Pfizer vaccine's efficacy declined from 96% to 84% four months after second dose, company reports.
34373255 2021. Covid-19: How effective are vaccines against the delta variant?
34429324 2021. Covid-19: 40% of patients with weakened immune system mount lower response to vaccines.
34259661 2021. Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia.
34227078 2021. Side effects after COVID-19 vaccinations among residents of Poland.
34197272 2021. Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance.
34196589 2021. Subacute thyroiditis following COVID-19 vaccination in a 67-year-old male patient: a case report.
34303332 2021. Genetics and Vaccine development for SARS-CoV2 in the era of Personalized Medicine.
34271824 2021. Thrombotic Thrombocytopenia and Central Venous Sinus Thrombosis Post - COVID-19 Vaccination and its Treatment with Heparin Alternatives.
34301834 2021. Mix and match COVID-19 vaccines: potential benefit and perspective from India.
34224542 2021. SARS-CoV-2 Vaccination and Antibody Testing in Immunosuppressed Populations: You Can't Tell the Players Without a Scorecard [RETRACTED].

34364905 2021. Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine in a Multicenter Cohort of Nursing Home Residents Receiving Maintenance Hemodialysis.
34352250 2021. Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2 messenger RNA vaccine.
34358478 2021. Adjustment is required to calculate the risk of early pregnancy loss with COVID-19 infection or vaccination.
34461029 2021. Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 : A Prospective Cohort Study.
34429320 2021. Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases.
34308389 2021. Sputnik V vaccine elicits seroconversion and neutralizing capacity to SARS-CoV-2 after a single dose.
34267349 2021. Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2.
34237213 2021. Thrombosis and severe acute respiratory syndrome coronavirus 2 vaccines: vaccine-induced immune thrombotic thrombocytopenia.
34222134 2021. A rare case of shingles after COVID-19 vaccine: is it a possible adverse effect?
34222133 2021. Acute myocarditis associated with anti-COVID-19 vaccination.
34280870 2021. Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up: A monocentre study.
34243079 2021. Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer.
34233234 2021. The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience.
34217909 2021. High levels of anti-SARS-CoV-2 IgG antibodies in previously infected patients with cancer after a single dose of BNT 162b2 vaccine.
34309530 2021. Considerations on SARS-Cov-2 vaccines in patients with autoimmune blistering diseases.
34263984 2021. Efficacy of the COVID-19 vaccine in heart transplant recipients: what we know and what we ignore.
34315774 2021. Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021.
34256983 2021. Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT).
34244023 2021. Vaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against COVID-19 pandemic: What pathogenesis?
34293217 2021. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency.
34264151 2021. Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines.
34313516 2021. Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2.
34288409 2021. COVID-19 vaccines: what do we know so far?
34213434 2021. COVID-19 vaccine effectiveness in preventing deaths among high-risk sgroups in Tamil Nadu, India.
34216120 2021. Which Group Should be Vaccinated First?: A Systematic Review.
34218826 2021. The use of antibody tests to determine level of immunity against coronavirus disease 2019 (COVID-19) after vaccination: A recent trend in India.
34289927 2021. SARS-CoV-2 vaccine breakthrough infections among healthcare workers in a large Belgian hospital network.
34261574 2021. Adverse events and humoral response after two doses of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) mRNA vaccine in the hospital personnel of a cardiopulmonary tertiary-care center.
34276178 2021. Delayed Skin Rash After Receiving SARS-CoV-2 mRNA Moderna Vaccine.
34276177 2021. Acute Necrotizing Rhombencephalitis and Disemminated Thrombosis After SARS-CoV-2 Infection.
34276176 2021. CDC Recommends Concurrent Immunizations: Does the COVID-19 Vaccination Campaign Offer Opportunities for Improving Vaccination Rates Across the Lifespan?
34286453 2021. Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular application of the vaccine?
34280851 2021. Autoimmune phenomena following SARS-CoV-2 vaccination.
34244309 2021. Do people reduce compliance with COVID-19 guidelines following vaccination? A longitudinal analysis of matched UK adults.
34310777 2021. New-onset acral lesions on hands after administration of mRNA-1273 vaccine against SARS-CoV-2: clinical images and histopathological study of three cases.
34310766 2021. Omalizumab prevents anaphylactoid reactions to mRNA COVID-19 vaccine.
34310763 2021. Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2.
34310759 2021. Small vessel vasculitis related to varicella-zoster virus after Pfizer-BioNTech COVID-19 vaccine.
34310755 2021. A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine.
34310754 2021. Herpes Zoster following SARS-CoV-2 vaccination - a series of four cases.
34309932 2021. New onset of mainly guttate psoriasis after COVID-19 vaccination: a case report.
34243220 2021. Transition of cutaneous into systemic lupus erythematosus following adenoviral vector-based SARS-CoV-2 vaccination.
34242422 2021. 'COVID arm' - histological features of a delayed-type hypersensitivity reaction to Moderna mRNA-1273 SARS-CoV2 vaccine.
34237178 2021. Pityriasis rosea developing after COVID-19 vaccination.
34236736 2021. Development of eruptive pseudoangiomatosis following COVID-19 immunization - Apropos of 5 cases.
34236735 2021. Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccine.
34236729 2021. Generalized eczematous reactions to the Pfizer-BioNTech COVID-19 vaccine.
34236728 2021. New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up after Sars-Cov-2 vaccination.
34236718 2021. New-onset cutaneous lichen planus triggered by COVID-19 vaccination.
34236717 2021. Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccine.
34310778 2021. Pityriasis rubra pilaris after Vaxzevria(R) COVID-19 vaccine.
34309085 2021. Retiform purpura and extensive skin necrosis as the single manifestation of SARS-CoV-2 infection.
34324939 2021. Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays.
34214517 2021. Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination.
34233149 2021. Importance of sample dilution in the evaluation of the antibody response after SARS-CoV-2 vaccination.
34214516 2021. Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.
34279930 2021. Potent Neutralizing Antibodies Elicited by RBD-Fc-Based COVID-19 Vaccine Candidate Adjuvanted by the Th2-Skewing iNKT Cell Agonist.
34316507 2021. Varicella zoster virus reactivation and mRNA vaccines as a trigger.
34316506 2021. Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination.
34222572 2021. Cutaneous mucormycosis following COVID-19 vaccination in a patient with bullous pemphigoid.
34192257 2021. Educational Resource Review: Vaccine development: finding a vaccine for COVID-19 and future pandemics.
34270945 2021. Comparison of BNT162b2 (Pfizer-BioNtech) and mRNA-1273 (Moderna) SARS-CoV-2 mRNA vaccine immunogenicity in dialysis patients.
34237324 2021. IgA nephropathy presenting as macroscopic hematuria in 2 pediatric patients after receiving the Pfizer COVID-19 vaccine.
34237323 2021. Granulomatous vasculitis after the AstraZeneca anti-SARS-CoV-2 vaccine.
34216675 2021. Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis.
34284044 2021. The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis.
34316525 2021. Neutralizing SARS-CoV-2 Antibody Response and Protective Effect of 2 Doses of ChAdOx1 nCoV-19 and BBV152 Vaccines in Hemodialysis Patients: A Preliminary Report.
34250319 2021. Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD.
34250318 2021. Nephrotic Syndrome Following ChAdOx1 nCoV-19 Vaccine Against SARScoV-2.
34278290 2021. IgA Nephropathy After SARS-CoV-2 Vaccination.
34274038 2021. Spike-antibody waning after second dose of BNT162b2 or ChAdOx1.
34270933 2021. Antibody response after second BNT162b2 dose in allogeneic HSCT recipients.
34246358 2021. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.
34274035 2021. Protecting the vulnerable: SARS-CoV-2 vaccination in immunosuppressed patients with interstitial lung disease.
34224675 2021. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
34307057 2021. SARS-CoV 2 spike protein S1 subunit as an ideal target for stable vaccines: A bioinformatic study.
34216636 2021. Optimal allocation of limited vaccine to minimize the effective reproduction number.
34230920 2021. Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines.
34223401 2021. FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.
34229883 2021. Unusual lymphadenopathies secondary to the BNT162b2 mRNA Covid-19 vaccine.
34229882 2021. Lesiones similares a perniosis tras vacunacion con ARNm frente a COVID-19.
34298479 2021. Key points to keep in mind related to COVID-19 vaccines in people with multiple sclerosis.
34298478 2021. Humoral response to SARS-CoV-2 COVID-19 vaccines in patients with multiple sclerosis treated with immune reconstitution therapies.
34260850 2021. Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
34233109 2021. Breakthrough SARS-CoV-2 Infections in Prison after Vaccination.
34192426 2021. Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.
34233097 2021. Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.
34320281 2021. Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
34192428 2021. Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
34233107 2021. Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia.
34232359 2021. Die Corona-Pandemie und Multiple Sklerose: Impfungen und deren Implikationen fur Patienten - Teil 1: Empfehlungen.
34232358 2021. Die Corona-Pandemie und Multiple Sklerose: Impfungen und deren Implikationen fur Patienten - Teil 2: Impfstofftechnologien.
34271959 2021. Gene therapies and COVID-19 vaccines: a necessary discussion in relation with viral vector-based approaches.
34270597 2021. Beyond the new normal: Assessing the feasibility of vaccine-based suppression of SARS-CoV-2.
34324966 2021. Developmental and reproductive safety of AZD1222 (ChAdOx1 nCoV-19) in mice.
34210623 2021. Side effects and antibody titer transition of the BNT162b2 messenger ribonucleic acid coronavirus disease 2019 vaccine in Japan.
34247902 2021. Henoch-Schonlein purpura presenting post COVID-19 vaccination.
34226102 2021. Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding.
34217573 2021. Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site.
34215453 2021. Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration.
34210574 2021. Tolerance of BNT162b2 mRNA COVI-19 vaccine in patients with a medical history of COVID-19 disease: A case control study.
34210573 2021. Evidence for antibody as a protective correlate for COVID-19 vaccines.
34272095 2021. Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-benefit analysis for people < 60 years in Australia.
34253420 2021. One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model.
34253419 2021. Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy- Update on the 28th of March 2021.
34275671 2021. Inadequate deltoid muscle penetration and concerns of improper COVID mRNA vaccine administration can be avoided by injection technique modification.
34340982 2021. Response to: Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli et al.
34340981 2021. Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli et al.
34340979 2021. Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response"by Bonelli et al.
34340978 2021. Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli et al.
34417362 2021. COVID-19 Vaccination Associated with Reduced Post-Operative SARS-CoV-2 Infection and Morbidity.
34227891 2021. Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2.

34406720 2021. COVID-19 rapid guideline: vaccine-induced immune thrombocytopenia and thrombosis (VITT)
34257025 2021. COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases.
34273260 2021. Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis.
34396603 2021. Large-Sized Graphene Oxide Nanosheets Increase DC-T-Cell Synaptic Contact and the Efficacy of DC Vaccines against SARS-CoV-2.
34377976 2021. Commentary on: A Case Report of Capsular Contracture Immediately Following COVID-19 Vaccination.
34373851 2021. A Case Report of Capsular Contracture Immediately Following COVID-19 Vaccination.
34394211 2020. Invited Editorial. COVID-19 Vaccine: Hope and reality.
34342475 2021. Perspectives on COVID-19 vaccination for pregnant women in South Africa.
34212542 2021. COVID-19 Vaccine-associated Anaphylaxis and Allergic Reactions: Consensus Statements of the KAAACI Urticaria/Angioedema/Anaphylaxis Working Group.
34249404 2021. Two Cases of Well Controlled Chronic Spontaneous Urticaria Triggered by the Moderna COVID-19 Vaccine.
34304240 2021. BNT162b2 mRNA Vaccine Interference with Co-Administration of Tdap Vaccine.
34285180 2021. A Case of Immune Thrombocytopenia After BNT162b2 mRNA COVID-19 Vaccination.
34254431 2021. Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19.
34241963 2021. Positive flow cytometry crossmatch with discrepant antibody testing results following COVID-19 vaccination.
34241964 2021. Antibodies, boosters, and optimizing SARS-CoV-2 vaccines for transplantation: A call for more research.
34328268 2021. Response to "SARS-CoV-2 vaccine effectiveness trumps immunogenicity in solid organ transplant recipients".
34212494 2021. SARS-CoV-2 vaccine effectiveness trumps immunogenicity in solid organ transplant recipients.
34249353 2021. Post-COVID-19 vaccine Guillain-Barre syndrome; first reported case from Qatar.
34336204 2021. Shoulder injury related to Sinovac COVID-19 vaccine: A case report.
34306673 2021. SARS-CoV-2 vaccinations are unsafe for those experiencing post-vaccination Guillain-Barre syndrome.
34324214 2021. Postvaccinal Encephalitis after ChAdOx1 nCov-19.
34333128 2021. Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients.
34362747 2021. Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression.
34286215 2021. Safety and immunogenicity evaluation of inactivated whole-virus-SARS-COV-2 as emerging vaccine development in Egypt.
34246566 2021. COVID-19 vaccines and myocarditis.
34280598 2021. COVID-19 vaccination and frailty in older adults.
34189565 2021. Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell-directed therapies.
34297792 2021. Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).
34280256 2021. Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.
34323939 2021. Prothrombotic immune thrombocytopenia after COVID-19 vaccination.
34255033 2021. Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination.
34187803 2021. Case of Guillain-Barre syndrome following COVID-19 vaccine.
34254291 2021. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.
34196388 2021. Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma.
34192245 2021. Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine.
34310400 2021. Immunogenicity and safety of a recombinant fusion protein vaccine (V-01) against coronavirus disease 2019 in healthy adults: a randomized, double-blind, placebo-controlled, phase II trial.
34231698 2021. Contexto de elaboracao do Plano de Imunizacao contra COVID-19 no Brasil.
34275963 2021. Frequent Premature Ventricular Contraction and Non-Sustained Ventricular Tachycardia After the SARS-CoV-2 Vaccination in Patient With Implantable Cardioverter Defibrillator Due to Acquired Long-QT Syndrome.
34235757 2021. Vaccine-induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage.
34272751 2021. Can COVID-19 immu" width="940" height="350" frameborder="0" scrolling="auto"> tion cause subacute thyroiditis?
34318537 2021. IgE-mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to mRNA COVID-19 vaccines.
34189756 2021. Cutaneous thrombosis associated with skin necrosis following Oxford-AstraZeneca COVID-19 vaccination.
34236714 2021. Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence?
34236711 2021. Vesiculobullous skin reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literature.
34291477 2021. Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination.
34288056 2021. Delayed localized hypersensitivity reactions to COVID-19 mRNA vaccines: a 6-month retrospective study.
34260095 2021. Severe cutaneous adverse reaction following COVID-19 vaccination and immunotherapy: a second hit?
34275716 2021. COVID-19 Vaccination in Oncology Patients Receiving Chemotherapy.
34243221 2021. US Taxpayers Heavily Funded the Discovery of COVID-19 Vaccines.
34241676 2021. Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients.
34241675 2021. SARS-CoV-2 vaccination in cardiothoracic organ transplant recipients: effective strategies wanted.
34241923 2021. Ethical considerations regarding COVID-19 vaccination for transplant candidates and recipients.
34327795 2021. Cutaneous lymphocytic vasculitis after administration of COVID-19 mRNA vaccine.
34245963 2021. Trend in COVID-19 vaccination among people with diabetes: A short study from India.
34275974 2021. Emergency use of COVID-19 vaccines recommended by the World Health Organization (WHO) as of June 2021.
34234059 2021. Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19.
34243217 2021. Subjektives Wohlbefinden und Arbeitsfahigkeit von Krankenhauspersonal nach SARS-CoV-2-Immunisierung mit dem mRNS-Impfstoff BNT162b2 - Ergebnisse einer anonymen Umfrage.
34233498 2021. Otolaryngology-Specific Symptoms May Be Highly Observed in Patients With a History of Covid-19 Infection After Inactivated Coronavirus Vaccination.
34308319 2021. Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India.
34308302 2021. Estimating the early impact of vaccination against COVID-19 on deaths among elderly people in Brazil: Analyses of routinely-collected data on vaccine coverage and mortality.
34226899 2021. Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca-Oxford COVID-19 vaccine.
34226903 2021. Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.
34314670 2021. Direct and Indirect Effectiveness of mRNA Vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 in Long-Term Care Facilities, Spain.
34289335 2021. Breakthrough Infections of SARS-CoV-2 Gamma Variant in Fully Vaccinated Gold Miners, French Guiana, 2021.
34304724 2021. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.
34289779 2021. Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19.
34278956 2021. Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine.
34232116 2021. Antibody titres decline 3-month post-vaccination with BNT162b2.
34197281 2021. Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trial.
34268278 2021. Renal Vein Thrombosis and Pulmonary Embolism Secondary to Vaccine-induced Thrombotic Thrombocytopenia (VITT).
34268277 2021. COVID-19 mRNA Vaccine and Myocarditis.
34268264 2021. The Meaning of SARS-CoV-2 Antibodies in a Patient with a Systemic Reaction to the mRNA-1273 SARS-CoV-2 Vaccine after Previous Natural Immunization.
34250222 2021. Current vaccine technology with an emphasis on recombinant measles virus as a new perspective for vaccination against SARS-CoV-2.
34266487 2021. COVID-19 vaccination associated severe immune thrombocytopenia.
34290613 2021. Targeting SARS-CoV-2-Platelet Interactions in COVID-19 and Vaccine-Related Thrombosis.
34290884 2021. An observational study of a cohort of citizens receiving the AZD1222 vaccine against SARS-CoV-2.
34249141 2021. Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer.
34270523 2021. Vacunas contra la COVID-19 y aparicion de variantes del SARS-CoV-2. Reflexionando sobre el caso de Mexico.
34224740 2021. BNT162b2 Messenger RNA COVID-19 Vaccine Effectiveness in Patients With Inflammatory Bowel Disease: Preliminary Real-World Data During Mass Vaccination Campaign.
34267426 2021. NOTTO COVID-19 Vaccine Guidelines for Transplant Recipients.
34315833 2021. Breastfeeding and Coronavirus Disease 2019 (COVID-19) Vaccination: Position Statement of Indian Academy of Pediatrics Advisory Committee on Vaccination and Immunization Practices.
34251026 2021. COVID-19 vaccination: possible short-term exacerbations of oral mucosal diseases.
34241833 2021. New-onset leukocytoclastic vasculitis after COVID-19 vaccine.
34244126 2021. COVID-19 vaccination among Spanish nephrologists: Acceptance and side effects.
34274181 2021. Paucisymptomatic COVID-19 in lung transplant recipient following two doses of mRNA-1273 (Moderna) vaccine.
34325728 2021. Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia.
34256064 2021. An unusual case of acute cholestatic hepatitis after m-RNABNT162b2 (Comirnaty) SARS-CoV-2 vaccine: Coincidence, autoimmunity or drug-related liver injury.
34245804 2021. The mRNA COVID-19 vaccine - A rare trigger of autoimmune hepatitis?
34189719 2021. Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience.
34304294 2021. Misinterpretation of glioblastoma as ADEM: potentially harmful consequences of over-diagnosis of COVID-19 vaccine-associated adverse events.
34253304 2021. COVID-19 Vaccination in Pregnancy: The Benefits Outweigh the Risks.
34273222 2021. Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine: COMMENT from Gruel et al.: RESPONSE from Kahn et al.
34226895 2021. A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS-CoV-2 variants and wild-type of the virus.
34212511 2021. COVID-19 vaccines are effective in people with obesity: A position statement from The Obesity Society.
34307734 2021. Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP.
34264546 2021. SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit.
34291552 2021. Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients.
34187780 2021. Covid-19: Third vaccine dose boosts immune response but may not be needed, say researchers.
34219142 2021. Tracking the pipeline: immunoinformatics and the COVID-19 vaccine design.
34213848 2021. SARS-CoV-2 vaccines, where do we stand?
34272229 2021. Patients with Solid Tumors Seroconvert after SARS-CoV-2 mRNA Vaccine.
34233902 2021. COVID-19 Vaccines Complicate Mammograms.
34269740 2021. Immunization practices and risk of anaphylaxis: a current update, comprehensive of COVID-19 vaccination data.
34314309 2021. COVID-19 Vaccine Reactions in Dermatology: "Filling" in the Gaps.
34231348 2021. Management of patients at risk of anaphylaxis after COVID 19 vaccination.
34261746 2021. Bilateral facial weakness with paraesthesia variant of Guillain-Barre syndrome following Vaxzevria COVID-19 vaccine.
34261345 Fall. Functional Neurological Disorder After SARS-CoV-2 Vaccines: Two Case Reports and Discussion of Potential Public Health Implications.
34301777 2021. Lessons learned from post-COVID-19 vaccination PET/CT studies.
34264684 2021. Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines.
34187278 2021. Acute Macular Neuroretinopathy following Coronavirus Disease 2019 Vaccination.
34282035 2021. Enhancement of Cell-based Vaccine Manufacturing Through Process Intensification.
34217513 2021. Guillain-Barre syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report.

34257485 2021. Addressing Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following COVID-19 Vaccination: A Mini-Review of Practical Strategies.
34436620 2021. Exacerbation of Hailey-Hailey Disease Following SARS-CoV-2 Vaccination.
34273119 2021. Large hemorrhagic stroke after ChAdOx1 nCoV-19 vaccination: A case report.
34366434 2021. Ulceras De Lipschutz Tras La Vacuna Frente A La Covid-19 De Astrazeneca.
34396358 2021. Myocarditis following mRNA vaccination against SARS-CoV-2, a case series.
34399967 2021. COVID-19 Vaccine and Myocarditis.
34364657 2021. Acute Myocardial Infarction Within 24 Hours After COVID-19 Vaccination.
34229940 2021. Myocarditis after BNT162b2 vaccination in a healthy male.
34274191 2021. A rare case of a middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination.
34389291 2021. COVID-19 vaccination during pregnancy: coverage and safety.
34425297 2021. Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy.
34411758 2021. COVID-19 vaccination in pregnancy: early experience from a single institution.
34236331 2021. Acute myocarditis after the second dose of SARS-CoV-2 vaccine: Serendipity or atypical causal relationship?
34288044 2021. COVID-19 Vaccine-Associated Cerebral Venous Thrombosis in Germany.
34231246 2021. Functional Neurological Disorders and COVID-19 Vaccination.
34342013 2021. Development, evaluation and use of COVID-19 vaccines in older adults: Preliminary principles for the pandemic and beyond.
34346068 2021. Serological SARS-CoV-2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID-19 vaccine in haematological and oncological patients.
34341984 2021. COVID symptoms, testing, shielding impact on patient-reported outcomes and early vaccine responses in individuals with multiple myeloma.
34405400 2021. Thrombotic thrombocytopenic purpura temporally associated with BNT162b2 vaccination in an adolescent successfully treated with caplacizumab.
34331459 2021. Hypothesis: Possible influence of antivector immunity and SARS-CoV-2 variants on efficacy of ChAdOx1 nCoV-19 vaccine.
34242573 2021. Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution.
34242572 2021. Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma.
34242571 2021. Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient.
34214473 2021. Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.
34298785 2021. COVID-19 Vaccine Safety in Cancer Patients: A Single Centre Experience.
34320400 2021. Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding.
34250287 2021. Effects of COVID-19 vaccination on FDG-PET/CT imaging: A literature review.
34278231 2021. Antibody Response After Initial Vaccination for SARS-CoV-2 in Patients With Amyloidosis.
34263143 2021. Autoimmune Hematologic Disorders in Two Patients After mRNA COVID-19 Vaccine.
34221846 2021. Prediction and identification of T cell epitopes of COVID-19 with balanced cytokine response for the development of peptide based vaccines.
34279767 2021. COVID-19 vaccines and decreased transmission of SARS-CoV-2.
34241782 2021. Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies.
34322977 2021. Perspectives of dermatology specialists and residents on COVID-19 vaccines: A questionnaire-based survey.
34228863 2021. Adverse reactions to Pfizer-BioNTech vaccination of healthcare workers at Malta's state hospital.
34289643 2021. The potential interaction between COVID-19 vaccines and clozapine: A novel approach for clinical trials.
34276266 2021. Lessons Learned from Cutting-Edge Immunoinformatics on Next-Generation COVID-19 Vaccine Research.
34276265 2021. New Computational Approach for Peptide Vaccine Design Against SARS-COV-2.
34191218 2021. Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines.
34233324 2021. Seropositive reaction rates of 9 B cell epitopes of the SARS-CoV-2 spike protein and the relationship between the epitopes and neutralizing antibody.
34226888 2021. China's COVID-19 vaccine approved for WHO emergency use listing.
34209801 2021. ISIDOG Consensus Guidelines on COVID-19 Vaccination for Women before, during and after Pregnancy.
34199053 2021. Systemic Adverse Events and Use of Antipyretics Predict the Neutralizing Antibody Positivity Early after the First Dose of ChAdOx1 Coronavirus Disease Vaccine.
34199029 2021. Levels of Produced Antibodies after Vaccination with mRNA Vaccine; Effect of Previous Infection with SARS-CoV-2.
34202324 2021. Vaccine Effects on Susceptibility and Symptomatology Can Change the Optimal Allocation of COVID-19 Vaccines: South Korea as an Example.
34267839 2021. Review of COVID-19 Variants and COVID-19 Vaccine Efficacy: What the Clinician Should Know?
34191577 2021. Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers.
34275536 2021. Evolution of our understanding of MS-COVID-19 interactions and concerns for vaccination.
34242802 2021. Vaccine or monoclonal therapy: which is the winning weapon against COVID-19?
34326999 2021. COVID-19 vaccinations are associated with reduced fatality rates: Evidence from cross-county quasi-experiments.
34254476 2021. Predicted and Observed Incidence of Thromboembolic Events among Koreans Vaccinated with ChAdOx1 nCoV-19 Vaccine.
34254475 2021. Emergency Department Utilization by In-hospital Healthcare Workers after COVID-19 Vaccination.
34243845 2021. Methodological Analysis: Randomized Controlled Trials for Pfizer and Moderna COVID-19 Vaccines.
34270752 2021. Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents.
34205301 2021. Antibody Response Following a Two-Dose mRNA Vaccination Regimen, in Health Care Workers of a Tertiary Hospital in Athens, Greece.
34236414 2021. Asymptomatic and Symptomatic COVID-19 Infections Among Health Care Personnel Before and After Vaccination.
34292295 2021. Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination.
34236381 2021. Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer.
34228115 2021. Evaluation of Messenger RNA From COVID-19 BTN162b2 and mRNA-1273 Vaccines in Human Milk.
34224668 2021. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
34224667 2021. Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma.
34224666 2021. Blunted humoral response after mRNA vaccine in patients with haematological malignancies.
34312612 2021. Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study.
34258590 2021. The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.
34258589 2021. Impact of methotrexate on first-dose COVID-19 mRNA vaccination.
34250509 2021. Reactivation of IgA vasculitis after COVID-19 vaccination.
34316728 2021. Adult-onset Still's disease following COVID-19 vaccination.
34316726 2021. Adult-onset Still's disease after mRNA COVID-19 vaccine.
34326466 2021. Response to mRNA vaccination for COVID-19 among patients with multiple myeloma.
34276917 2021. A Rare Case of Superior Ophthalmic Vein Thrombosis and Thrombocytopenia Following ChAdOx1 nCoV-19 Vaccine Against SARS-CoV-2.
34276916 2021. Immune Thrombocytopenic Purpura Cases Following COVID-19 Vaccination.
34237049 2021. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
34192737 2021. Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.
34219853 2021. Un caso de Nefritis tubulointersticial aguda despues de la vacunacion con Pfizer-BioNTech COVID-19.
34289075 2021. COVID-19 vaccination in haemodialysis patients: good things come in threes....
34289072 2021. SARS-CoV-2 vaccination in patients receiving kidney replacement therapies: where are we now with the protective immune response?
34245294 2021. Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial?
34305020 2021. Vaccination anti-COVID-19 chez les patients dialyses et transplantes renaux.
34189176 2021. BNT162b2 Vaccine Effectiveness in Preventing Asymptomatic Infection With SARS-CoV-2 Virus: A Nationwide Historical Cohort Study.
34314563 2021. The COVID-19 vaccine and interventional procedures: Exploring the relationship between steroid administration and subsequent vaccine efficacy.
34313952 2021. Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study.
34239977 2021. Deep sequence modelling for predicting COVID-19 mRNA vaccine degradation.
34316263 2021. NICE to publish guidelines for rare blood clotting syndrome from COVID-19 vaccination.
34220197 2021. Pfizer COVID-19 vaccine recommended for pregnant women in Australia and New Zealand.
34276271 2021. Pravention durch Impfung pneumologisch vorerkrankter Erwachsener: Pneumokokkenpneumonie, Influenza, Pertussis, Herpes Zoster und "coronavirus disease 2019".
34193524 2021. Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.
34284878 2021. Effect of SARS-CoV-2 vaccination among health care workers in a geriatric care unit after a B.1.1.7-variant outbreak.
34230759 2021. Detection of an appropriate pharmaceutical company to get a suitable vaccine against COVID-19 with minimum cost under the quality control process.
34305033 2021. SARS-CoV-2 vaccination and metabolic radionuclide therapy: Document of the SEMNIM Endocrinology Working Group.
34286893 2021. Potency of BNT162b2 and mRNA-1273 vaccine-induced neutralizing antibodies against severe acute respiratory syndrome-CoV-2 variants of concern: A systematic review of in vitro studies.
34197678 2021. Vaccine-induced immune thrombotic thrombocytopenia after vaccination against Covid-19: A clinical dilemma for clinicians and patients.
34249121 2021. Dealing with perceptions related to thrombosis and COVID-19 vaccines.
34305424 2021. Covid-19 Vaccine Surveillance in Saudi Arabia: Opportunities for Real-time Assessment.
34267221 2021. A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.
34234098 2021. Catch-as-catch-can: mRNA vaccination boosts immune responses to SARS-CoV-2 variants.
34274941 2021. A bivalent recombinant vaccine: a promising strategy against both SARS-CoV-2 variants and wild type of the virus.
34267185 2021. Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.
34304601 2021. Cerebral Vein Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia.
34244449 2021. Successful management of vaccine-induced immune thrombotic thrombocytopenia-related cerebral sinus venous thrombosis after ChAdOx1 nCov-19 vaccination.
34272069 2021. Eruption eczematiforme apres le vaccin par Pfizer-BioNTech COVID-19.
34238585 2021. COVID-19 vaccines and pregnancy: What do we know?
34238706 2021. Blood donor deferral periods after COVID-19 vaccination.
34406140 2021. SARS-CoV-2 Immunization in Patients With Inflammatory Bowel Disease May Result in Disease Flares.
34404083 2021. COVID-19 Vaccine for Chronic Gastroenterology and Hepatology Patients: A Need for Better Evidence.
34446440 2021. Initial experience of the safety and tolerability of the BNT162b2 (Pfizer-Bio-N-Tech) vaccine in extremely vulnerable children aged 12-15 years.
34346185 2021. Disease Flare and Reactogenicity in Patients with Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination.
34373256 2021. Transparency of COVID-19 vaccine trials: decisions without data.
34423463 2021. A case of acute necrotising pancreatitis following the second dose of Pfizer-BioNTech COVID-19 mRNA vaccine.
34427487 2021. Detection of SARS-CoV-2-Specific IgA in the Human Milk of COVID-19 Vaccinated Lactating Health Care Workers.
34424542 2021. Ongoing research examines COVID-19 vaccination effectiveness in patients with cancer and survivors.
34227767 2021. COVID-19 Immunity to Vaccination in India.
34225251 2021. Auto-immune hepatitis following COVID vaccination.
34219684 2021. Determining the frequency of serious adverse reactions of inactive SARS-COV-2 vaccine.

34191300 2021. COVID-19 vaccines - the way forward.
34286856 2021. Antibody response after one and two jabs of the BNT162b2 vaccine in nursing home residents: The CONsort-19 study.
34245591 2021. A bird's eye view on the role of dendritic cells in SARS-CoV-2 infection: Perspectives for immune-based vaccines.
34251905 2021. The Case for Mandating COVID-19 Vaccines for Health Care Workers.
34280332 2021. SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting.
34285048 2021. SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity.
34235643 2021. Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines.
34196506 2021. Brief Report: Humoral and cellular immune responses to SARS-CoV-2 infection and vaccination in B cell depleted autoimmune patients.
34196469 2021. A case of leukocytoclastic vasculitis after vaccination with a SARS-CoV2-vaccine - a case report.
34276817 2021. Advances of mRNA vaccines for COVID-19: A new prophylactic revolution begins.
34228815 2021. Primary cutaneous anaplastic large-cell lymphoma with marked spontaneous regression of organ manifestation after SARS-CoV-2 vaccination.
34281357 2021. Myocarditis With COVID-19 mRNA Vaccines.
34341683 2021. Seroconversion after COVID-19 vaccine in a dialysis patient on immunosuppressants.
34384875 2021. COVID-19 vaccination in Israel.
34418708 2021. Guillain-Barre syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?
34190859 2021. CoronaVac can induce the production of anti-SARS-CoV-2 IgA antibodies in human milk.
34226271 2021. Ischemie d'un membre et thrombose de l'artere pulmonaire apres l'administration du vaccin ChAdOx1 nCoV-19 (Oxford-AstraZeneca) : un cas de thrombocytopenie thrombotique immunitaire induite par le vaccin.
34330017 2021. COVID-19 vaccines.
34232548 2021. COVID-19 vaccines: What dermatologists should know?
34232544 2021. The initial experience of COVID-19 vaccination in autoimmune blistering diseases patients from a reference care center in Italy.
34231301 2021. Exacerbation of psoriasis following COVID-19 vaccination in a patient previously treated with PD-1 inhibitor.
34410574 2021. COVID-19 Vaccination in Patients with Inflammatory Bowel Disease: A Survey from China.
34393073 2021. Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients.
34332100 2021. Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management.
34347278 2021. Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report.
34351606 2021. Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2.
34366660 2021. Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems.
34374333 2021. Pityriasis Rosea as a Possible Complication of Vaccination Against COVID-19.
34454402 2021. Vaccine against SARS-CoV-2 in previously infected health care workers.
34454401 2021. Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis.
34391096 2021. Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis.
34391088 2021. Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.
34391087 2021. B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19.
34414368 2021. Safety and immunogenicity of a QazCovid-in(R) inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan.
34459725 2021. Fatal Systemic Capillary Leak Syndrome after SARS-CoV-2Vaccination in Patient with Multiple Myeloma.
34427172 2021. Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies.
34365904 2021. Live attenuated coronavirus vaccines deficient in N7-Methyltransferase activity induce both humoral and cellular immune responses in mice.
34399446 2021. COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society.
34334861 2021. EVOLUCION DE LOS CASOS DE TOS FERINA TRAS LA VACUNACION DE LA EMBARAZADA Y LA PANDEMIA COVID-19.
34334860 2021. Effectiveness of the BNT162b2 mRNA Covid-19 Vaccine in Spanish Healthcare Workers.
34457370 2021. A vaccine based on the receptor-binding domain of the spike protein expressed in glycoengineered Pichia pastoris targeting SARS-CoV-2 stimulates neutralizing and protective antibody responses.
34405870 2021. Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia.
34254358 2021. Participation in ENSEMBLE phase III multicenter clinical trial of Ad26.CoV2.S, a COVID-19 vaccine: An investigational drug services perspective.
34363731 2021. Pityriasis rosea following SARS-CoV-2 vaccination: A case series.
34292611 2021. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination.
34370344 2021. Cutaneous reactions following CoronaVac COVID-19 vaccination: a case series of six healthcare workers from a single centre.
34363717 2021. Herpes zoster after ChAdOx1 nCoV-19 vaccine: a case series.
34363713 2021. Cutaneous reactions to inactivated SARS-CoV-2 vaccine and ChAdOx1-S (recombinant) vaccine against SARS-CoV-2: a case series from the Philippines.
34363647 2021. Psoriasis exacerbation after COVID-19 vaccination: a report of 14 cases from a single centre.
34363637 2021. Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature.
34363258 2021. Three cases of vesiculobullous non-IgE-mediated cutaneous reactions to tozinameran (Pfizer-BioNTech COVID-19 vaccine).
34363257 2021. Herpes zoster after inactivated SARS-CoV-2 vaccine in two healthy young adults.
34416058 2021. A Bullous Eruption following the Pfizer-BioNTech COVID-19 vaccination.
34296443 2021. Effectiveness of COVID-19 vaccines: findings from real world studies.
34368991 2021. Severe Dyskinesia After Administration of SARS-CoV2 mRNA Vaccine in Parkinson's Disease.
34279842 2021. The Worldwide Effort to Develop Vaccines for COVID-19.
34259040 2021. FDG-Avid Ipsilateral Iliac and Inguinal Lymphadenopathy After COVID-19 Vaccination With Thigh Injection.
34187985 2021. Gastroparesis After Pfizer-BioNTech COVID-19 Vaccination.
34272251 2021. Response to: 'Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response by Westhoff et al.
34187777 2021. Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'.
34210672 2021. Covid-19: Pfizer vaccine could provide lasting immunity, small study suggests.
34366403 2021. Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines.
34433191 2021. The impact of COVID-19 in pregnancy: Part II. Vaccination to pregnant women.
34301797 2021. Haemophagocytic lymphohistiocytosis after ChAdOx1 nCoV-19 vaccination.
34418261 2021. Systemic lupus erythematosus after COVID-19 vaccination: A case report.
34229482 2021. Delayed Cutaneous Reactivity Associated With COVID-19 Vaccines Is Rare.
34459023 2021. Five Japanese cases of delayed large local reactions to coronavirus disease 2019 vaccines.
34284839 2021. COVID-19 age-dependent immunology and clinical outcomes: implications for vaccines.
34397201 2021. Herpes Zoster Following COVID-19 Vaccination.
34459036 2021. Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccines.
34416052 2021. Flagellate purpura associated with COVID-19 vaccination.
34416044 2021. Two cases of papulo-pustular rosacea-like eruptions following COVID-19 vaccinations.
34297036 2021. Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses.
34287620 2021. Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples.
34259836 2021. Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination.
34251417 2021. Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.
34319363 2021. Association of Facial Pustular Neutrophilic Eruption With Messenger RNA-1273 SARS-CoV-2 Vaccine.
34254978 2021. Association of BNT162b2 mRNA and mRNA-1273 Vaccines With COVID-19 Infection and Hospitalization Among Patients With Cirrhosis.
34309623 2021. Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose.
34432329 2021. Effects of the Coronavirus Disease 2019 Pandemic on Motor Symptoms in Parkinson's Disease: An Observational Study.
34387536 2021. SARS-CoV-2 antibodies in multiple sclerosis patients depending on the vaccine mode of action?
34379914 2021. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
34437789 2021. Audio Interview: Assessing Vaccine Safety.
34379932 2021. Audio Interview: Monoclonal Antibodies and Booster Shots.
34429547 2021. Intranasal vaccination.
34331051 2021. Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial.
34381200 2021. Reasons for success and lessons learnt from nanoscale vaccines against COVID-19.
34408308 2021. Antibodies reveal who's protected by Moderna's COVID vaccine.
34404949 2021. Daily briefing: Iran's home-grown COVID-19 vaccines.
34429544 2021. COVID vaccines and blood clots: what researchers know so far.
34408311 2021. Decades-old SARS virus infection triggers potent response to COVID vaccines.
34404947 2021. Iran hopes to defeat COVID with home-grown crop of vaccines.
34354274 2021. COVID vaccine boosters: the most important questions.
34345036 2020. Daily briefing: World's largest vaccine maker bets on Oxford coronavirus candidate.
34376851 2020. Daily briefing: Russia approves 'reckless' coronavirus vaccine.
34346657 2021. Verwardheid en buikpijn na covid-19-vaccinatie.
34346643 2021. 'Vaccine-induced immune thrombotic trombocytopenia'.
34351716 2021. COVID-19-vaccins: hoe zit het?
34450648 2021. Weekly seroconversion rate of the mRNA-1273 SARS-CoV-2 vaccine in haemodialysis patients.
34450646 2021. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in a haemodialysis cohort.
34333995 2021. Cerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia.
34412144 2021. FDG uptake in axillaren Lymphknoten nach COVID-19 Impfung - ein Fallstrick in der Interpretation eines FDG-PET/CT bei einem Patienten mit malignem Melanom und hochgradig Metastasen-suspekten axillaren Lymphknoten.
34344280 2021. Bilateral Multifocal Choroiditis following COVID-19 Vaccination.
34213988 2021. Panuveitis following Vaccination for COVID-19.
34406890 2021. COVID-19 Vaccination and Bilateral Multifocal Choroiditis.
34402726 2021. Acute Thyroiditis and Bilateral Optic Neuritis following SARS-CoV-2 Vaccination with CoronaVac: A Case Report.
34379565 2021. Acute Uveitis following COVID-19 Vaccination.
34272340 2021. Important Considerations for COVID-19 Vaccination of Children With Developmental Disabilities.
34282971 2021. Myocarditis Associated with mRNA COVID-19 Vaccination.
34310229 2021. Evolution of Lymphadenopathy at PET/MRI after COVID-19 Vaccination.
34303337 2021. Nanovaccine: A hope to triumph the battle against novel Coronavirus disease 2019 (COVID-19).
34192840 2021. [Rapid guideline for COVID-19 vaccination in patients with chronic liver diseases, hepatolbiliary malignancy and liver transplant].

34421121 2021. Deep survey for designing a vaccine against SARS-CoV-2 and its new mutations.
34356507 2021. Lymphadenopathy after the Anti-COVID-19 Vaccine: Multiparametric Ultrasound Findings.
34439984 2021. Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers.
34343897 2021. Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2.
34440072 2021. Immune Assessment of BNT162b2 m-RNA-Spike Based Vaccine Response in Adults.
34440163 2021. COVID-19 Disease, Women's Predominant Non-Heparin Vaccine-Induced Thrombotic Thrombocytopenia and Kounis Syndrome: A Passepartout Cytokine Storm Interplay.
34440239 2021. Picture of the Favourable Immune Profile Induced by Anti-SARS-CoV-2 Vaccination.
34356644 2021. COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street?
34339501 2021. Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy.
34387648 2021. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma.
34387646 2021. Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies.
34330895 2021. Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia.
34341335 2021. The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment.
34376633 2021. Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies.
34397451 2021. Subcutaneous injection of mRNA vaccines against severe acute respiratory syndrome coronavirus 2: an option for severe bleeding disorders or anticoagulated patients?
34348657 2021. Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report.
34420521 2021. Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naive recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients.
34446426 2021. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.
34417194 2021. Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study.
34417165 2021. Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study.
34407952 2021. Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study.
34330729 2021. Guillain-Barre syndrome after COVID-19 vaccination.
34330722 2021. Immune thrombocytopenic purpura and acute liver injury after COVID-19 vaccine.
34348912 2021. Remitting seronegative symmetrical synovitis with pitting oedema following BNT162b2 mRNA COVID-19 vaccination.
34400433 2021. Extensive thrombosis after COVID-19 vaccine: cause or coincidence?
34405142 2021. Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational cohort study.
34396084 2021. SARS CoV2 vaccine and aphasia.
34456555 2021. A systematic review of effectiveness of BNT162b2 mRNA and ChAdOx1 adenoviral vector COVID-19 vaccines in the general population.
34375696 2021. Myocarditis and Pericarditis After COVID-19 mRNA Vaccination: Practical Considerations for Care Providers.
34450047 2021. Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer.
34348121 2021. Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer.
34331856 2021. Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies.
34359701 2021. Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 Treatment.
34439346 2021. Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs.
34420869 2021. Temporal association between the COVID-19 Ad26.COV2.S vaccine and acute myocarditis: A case report and literature review.
34395000 2021. Oxford-AstraZeneca Coronavirus Disease-2019 Vaccine-Induced Immune Thrombocytopenia on Day Two.
34344867 2021. Thromboembolism after COVID-19 vaccine in patients with preexisting thrombocytopenia.
34408130 2021. Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infection.
34400614 2021. Humoral responses in naive or SARS-CoV-2 experienced individuals vaccinated with an inactivated vaccine.
34400612 2021. Systematic profiling of SARS-CoV-2-specific IgG responses elicited by an inactivated virus vaccine identifies peptides and proteins for predicting vaccination efficacy.
34373443 2021. Integrated single-cell analysis revealed immune dynamics during Ad5-nCoV immunization.
34428428 2021. An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates.
34450033 2021. Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2.
34411541 2021. Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals.
34390647 2021. Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals.
34352226 2021. Systemic IL-15, IFN-gamma, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients.
34341489 2021. Time of day influences immune response to an inactivated vaccine against SARS-CoV-2.
34440721 2021. Differences in the Concentration of Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 Recovery or Post-Vaccination.
34440710 2021. Kinetics of Anti-SARS-CoV-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health Workers.
34407651 2021. Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study.
34356586 2021. Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?
34414339 2021. Intense Emotional Stress Over Potential Coronavirus Disease Vaccination Side Effects Leads to Takotsubo Cardiomyopathy.
34429981 2021. Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination.
34358295 2021. Poor Humoral Response in Solid Organ Transplant Recipients following Complete mRNA SARS-CoV-2 Vaccination.
34358373 2021. ChAdOx1 SARS-CoV-2 vaccination: A putative precipitant of adrenal crises.
34415637 2021. Allergic and cutaneous reactions following inactivated SARS-CoV-2 vaccine (CoronaVac((R)) ) in healthcare workers.
34399001 2021. Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination.
34398977 2021. De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccine.
34379821 2021. Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine.
34340203 2021. Mammographic and sonographic findings in the breast and axillary tail following a COVID-19 vaccine.
34358692 2021. Guillain-Barre syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine.
34363462 2021. Determining the Incidence of Asymptomatic SARS-CoV-2 among Early Recipients of COVID-19 Vaccines: A Prospective Cohort Study of Healthcare Workers before, during and after Vaccination [DISCOVER-COVID-19].
34358310 2021. Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States.
34460902 2021. Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada.
34343259 2021. Differential anti-S antibody titers in vaccinated residents during an outbreak of SARS-CoV-2 variant B.1.351 (beta) in an elderly nursing home.
34410361 2021. Post-vaccination COVID-19: A case-control study and genomic analysis of 119 breakthrough infections in partially vaccinated individuals.
34406358 2021. Intravenous injection of COVID-19 mRNA vaccine can induce acute myopericarditis in mouse model.
34383902 2021. Heterologous ChAdOx1-S/BNT162b2 vaccination: neutralizing antibody response to SARS-CoV-2.
34429940 2021. Vaccination against COVID-19 in a haemodialysis centre: what is the risk of bleeding complications?
34371204 2021. Both SARS-CoV-2 infection and vaccination in pregnancy elicited neutralizing antibodies in pregnant women and newborns.
34375755 2021. Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan.
34438069 2021. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1.
34428593 2021. Which are the best coronavirus disease 2019 vaccines?
34391930 2021. Precautions after vaccinating immunosuppressed patients with mRNA-based vaccines against SARS-CoV-2: does one size fit all?
34414880 2021. Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021.
34355689 2021. Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021.
34383900 2021. Brugada syndrome and COVID-19 vaccines.
34365880 2021. Sars-Cov-2 virus and vaccination; biological and statistical framework.
34415818 2021. To mix or not to mix? A rapid systematic review of heterologous prime-boost covid-19 vaccination.
34338126 2021. COVID-19 vaccines approved in the European Union: current evidence and perspectives.
34426655 2021. Corneal graft rejection following COVID-19 vaccine.
34331769 2021. Single-dose immu" width="940" height="350" frameborder="0" scrolling="auto"> tion with a multimerised SARS-CoV-2 receptor binding domain (RBD) induces an enhanced and protective response in mice.
34386486 2021. Development and Delivery Systems of mRNA Vaccines.
34447374 2021. COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial.
34386018 2021. HLA Does Not Impact on Short-Medium-Term Antibody Response to Preventive Anti-SARS-Cov-2 Vaccine.
34368197 2021. Case Report: Infection With SARS-CoV-2 in the Presence of High Levels of Vaccine-Induced Neutralizing Antibody Responses.
34427272 2021. Facial nerve palsy after COVID-19 vaccination - A rare association or a coincidence.
34427638 2021. Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients.
34363344 2021. Arthritis of the left elbow joint after vaccination against SARS-CoV-2 infection.
34350721 2021. A vaccination update for rheumatologists-SARS-CoV-2, influenza and herpes zoster.
34431530 2021. COVID-19 vaccination and exanthema-like eruption.
34453510 2021. Insights from a murine model of COVID-19 mRNA vaccination-induced myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis?
34355678 2021. Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARS-CoV-2 Infection.
34334663 2021. Anaphylaxis and Coronavirus Disease 2019 vaccine: a danger relationship?
34455671 2021. Subacute cutaneous lupus erythematosus flare triggered by COVID-19 vaccine.
34427024 2021. Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID-19 vaccines: A report of two cases.
34432391 2021. COVID-19 post-vaccination lymphadenopathy: Report of cytological findings from fine needle aspiration biopsy.
34391596 2021. Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers.
34344559 2021. Sindrome de Ramsay Hunt tras vacunacion con m-RNA SARS-COV-2.
34399868 2021. SARS-CoV-2 Immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021.
34355379 2021. Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: a report of an autoptic case and review of the literature.
34357839 2021. Safety of COVID-19 vaccines in patients with psoriasis undergoing therapy with anti-interleukin agents.
34192777 2021. COVID-19: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
34413252 2021. Serological response to mRNA and inactivated COVID-19 vaccine in healthcare workers in Hong Kong: preliminary results.
34347563 2021. Electromyoneurography and laboratory findings in a case of Guillain-Barre syndrome after second dose of Pfizer COVID-19 vaccine.
34435935 2021. Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine.
34406914 2021. Protecting adults at risk of pneumococcal infection and influenza from exposure to SARS-CoV-2.
34348908 2021. Immunogenicity of SARS-CoV-2 Vaccine in Dialysis.
34382563 2021. Considerations for COVID-19 vaccination in pregnancy.
34382561 2021. Recommendations for the diagnosis and management of vaccine-induced immune thrombotic thrombocytopenia.
34382557 2021. The J&J COVID-19 vaccine: Fit for purpose in our setting.
34376569 2021. Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection.

34333695 2021. Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis?
34331522 2021. Patients with suspected allergic reactions to COVID-19 vaccines can be safely revaccinated after diagnostic work-up.
34408875 2021. Rapid whole-blood assay to detect SARS-CoV-2-specific memory T-cell immunity following a single dose of AstraZeneca ChAdOx1-S COVID-19 vaccine.
34362727 2021. Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford-AstraZeneca) vaccination.
34344774 2021. Bacillus Calmette-Guerin scar flare after an mRNA SARS-CoV-2 vaccine.
34381159 2021. Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration.
34352457 2021. An in-depth in silico and immunoinformatics approach for designing a potential multi-epitope construct for the effective development of vaccine to combat against SARS-CoV-2 encompassing variants of concern and interest.
34331834 2021. Application of quantitative systems pharmacology to guide the optimal dosing of COVID-19 vaccines.
34336436 2021. Bell's Palsy After 24 Hours of mRNA-1273 SARS-CoV-2 Vaccine.
34458035 2021. SARS-CoV-2 Vaccination-Induced Transverse Myelitis.
34447649 2021. Thrombotic Thrombocytopenic Purpura Presentation in an Elderly Gentleman Following COVID Vaccine Circumstances.
34447646 2021. Facial Diplegia: A Rare, Atypical Variant of Guillain-Barre Syndrome and Ad26.COV2.S Vaccine.
34447639 2021. Unusual Presentation of Acute Perimyocarditis Following SARS-COV-2 mRNA-1237 Moderna Vaccination.
34430106 2021. Drug-Induced Liver Injury After COVID-19 Vaccine.
34408937 2021. A COVID-Positive 52-Year-Old Man Presented With Venous Thromboembolism and Disseminated Intravascular Coagulation Following Johnson & Johnson Vaccination: A Case-Study.
34367780 2021. Two Cases of Post-Moderna COVID-19 Vaccine Encephalopathy Associated With Nonconvulsive Status Epilepticus.
34367770 2021. Epidemiological Study of COVID-19 Fatalities and Vaccine Uptake: Insight From a Public Health Database in Ontario, Canada.
34369046 2021. COVID-19 vaccine-induced urticarial vasculitis.
34350668 2021. Onset/flare of psoriasis following the ChAdOx1 nCoV-19 Corona virus vaccine (Oxford-AstraZeneca/Covishield): Report of two cases.
34364299 2021. Evaluation of the dose-effect association between the number of doses and duration since the last dose of COVID-19 vaccine, and its efficacy in preventing the disease and reducing disease severity: A single centre, cross-sectional analytical study from India.
34450248 2021. Short-term safety profile of Sars-Cov2 vaccination on glucose control: Continuous glucose monitoring data in people with autoimmune diabetes.
34332306 2021. Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays.
34400057 2021. COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors.
34438245 2021. Safety and immunogenicity after 2 doses of the BNT162b2 COVID-19 vaccine in an early-phase oncology trial centre population.
34428684 2021. Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix.
34337738 2021. Serum antibody response to BNT162b2 after natural SARS-CoV-2 infection.
34363519 2021. Hypertension and Covid-19 vaccines: are there any differences between the different vaccines? A safety signal.
34419309 2021. ChAdOx1 nCoV-19 effectiveness during an unprecedented surge in SARS COV-2 infections.
34433495 2021. Delayed skin reaction after mRNA-1273 vaccine against SARS-CoV-2: a rare clinical reaction.
34447349 2021. Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report.
34393988 2021. Vaccine Induced Immune Thrombotic Thrombocytopenia Causing a Severe Form of Cerebral Venous Thrombosis With High Fatality Rate: A Case Series.
34414110 2021. Interference of COVID-19 Vaccination With PET/CT Leads to Unnecessary Additional Imaging in a Patient With Metastatic Cutaneous Melanoma-Case Report.
34352148 2021. Immunity to SARS-CoV-2 induced by infection or vaccination.
34397348 2021. Immunogenicity after the first dose of the BNT162b2 mRNA Covid-19 vaccine: real-world evidence from Greek healthcare workers.
34453830 2021. Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients.
34353858 2021. Vaccination and multiple sclerosis in the era of the COVID-19 pandemic.
34412098 2021. Anti-SARS-CoV-2 IgA Response in Baseline Seronegative and Seropositive Recipients of BNT162b2 mRNA COVID-19 Vaccine.
34332972 2021. Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents.
34379509 2021. A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters.
34407309 2021. Antibody Response to Severe Acute Respiratory Syndrome-Coronavirus-2 Messenger RNA Vaccines in Liver Transplant Recipients.
34398511 2021. Safety of administration of BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG-asparaginase.
34331506 2021. Thrombocytopenia in a teen with sickle cell disease following COVID-19 vaccination.
34411407 2021. Comment on: Thrombocytopenia in a teen with sickle cell disease following COVID-19 vaccination.
34432063 2021. ChAdOx1 COVID-19 vaccine-induced thrombocytopenia syndrome.
34432055 2021. Myeloperoxidase Anti-neutrophil Cytoplasmic Antibody Positive Optic Perineuritis after mRNA Coronavirus Disease-19 Vaccine: A Case Report.
34402669 2021. Parsonage-Turner Syndrome Following COVID-19 Vaccination: MR Neurography.
34402666 2021. Imaging and Hematologic Findings in Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 (AstraZeneca) Vaccination.
34387243 2021. Immune Response Post-SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Receiving Belatacept.
34381004 2021. Serological Response to the BNT162b2 COVID-19 mRNA Vaccine in Adolescent and Young Adult Kidney Transplant Recipients.
34342963 2021. Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant.
34455752 2021. [SARS-CoV-2 vaccines induced immune thrombotic thrombocytopenia].
34406398 2021. Interpreting prevention of COVID-19 and vaccines.
34427924 2021. The effectiveness of inactivated SARS-CoV-2 vaccine (CoronaVac) on antibody response in participants aged 65 years and older.
34453849 2021. COVID-19 Vaccine among Actively-Treated People with Cancer: A Glimpse into the Known Unknowns?
34453841 2021. Prioritizing Cancer Patients for Vaccination in India.
34362855 2021. Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder.
34341144 2021. What should we do about vaccination of patients on anti-CD20 antibody therapy?
34408003 2021. mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis.
34369471 2021. Transient Oculomotor Palsy Following the Administration of the Messenger RNA-1273 Vaccine for SARS-CoV-2 Diplopia Following the COVID-19 Vaccine.
34420249 2021. Newly diagnosed immune thrombocytopenia in a pregnant patient after coronavirus disease 2019 vaccination.
34347673 2021. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination for Paediatric Patients With Inflammatory Bowel Diseases.
34347001 2021. Myocarditis and Pericarditis After Vaccination for COVID-19.
34459863 2021. Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.
34374737 2021. Oldest Adults Need 2 mRNA Vaccine Doses to Neutralize SARS-CoV-2.
34374736 2021. COVID-19 mRNA Vaccines Blunt Breakthrough Infection Severity.
34374740 2021. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children.
34374713 2021. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.
34398185 2021. Caution in Interpreting Facial Paralysis Data to Understand COVID-19 Vaccination Risks.
34398177 2021. Caution in Interpreting Facial Paralysis Data to Understand COVID-19 Vaccination Risks-Reply.
34379085 2021. Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease.
34431208 2021. Guillain-Barre syndrome after COVID-19 mRNA vaccination in a liver transplant recipient with favorable treatment response.
34416086 2021. New-Onset Antibodies to Platelet Factor 4 Following Liver Transplantation From a Donor With Vaccine-Induced Thrombotic Thrombocytopenia.
34408089 2021. SARS-CoV-2 Antibodies in Breast Milk After Vaccination.
34389692 2021. COVID-19 Vaccination-Associated Myocarditis in Adolescents.
34362856 2021. Review of COVID-19 vaccine subtypes, efficacy and geographical distributions.
34446449 2021. Acute immune thrombocytopenic purpura post first dose of COVID-19 vaccination.
34446448 2021. Multisystem inflammatory syndrome after SARS-CoV-2 vaccination (MIS-V), to interpret with caution.
34347105 2021. Neuralgic amyotrophy following COVID-19 mRNA vaccination.
34450645 2021. Emergence of new onset SLE following SARS-CoV-2 vaccination.
34415336 2021. IgA nephropathy flare-up following SARS-CoV-2 vaccination.
34369440 2021. Uveitis following the BNT162b2 mRNA vaccination against SARS-CoV-2 infection: a possible association.
34373413 2021. [Cerebral vein/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccination].
34385356 2021. Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.
34362838 2021. COVID-19 vaccine-related interstitial lung disease: a case study.
34352912 2021. Modeling the Effects of Intravasal Administration of AstraZeneca ChAdOx1 nCoV-19 Vaccine on Human Platelets.
34352911 2021. Autoimmunity after Coronavirus Disease 2019 (COVID-19) Vaccine: A Case of Acquired Hemophilia A.
34388849 2021. Platelet Surface Protein Expression and Reactivity upon TRAP Stimulation after BNT162b2 Vaccination.
34450686 2021. SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know.
34456266 2021. Preemptive Antibody Therapy for Vaccine Breakthrough SARS-CoV-2 Infection in Immunocompromised Patients.
34428188 2021. Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
34406187 2021. SARS-CoV-2 Infection After Full Vaccination in Kidney Transplant Recipients.
34356021 2021. [SARS-CoV-2 vaccine-induced immune thrombosis and thrombocytopenia].